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The contribution of retinal ganglion cells (RGCs) to human electroretinograms (ERGs) is known, but 
that of chicken (Gallus gallus domesticus) is not clear. This project seeks to determine the effect of 
RGC dysfunction on full-field flash ERGs in chickens using established protocols known to test RGC 
function in humans and other mammals.  
Chicks were treated to produce unilateral retinal dysfunction by surgical optic nerve section (ONS 
group) or by intravitreal injection of tetrodotoxin (TTX group) to block ganglion cell function.  
Contralateral eyes received sham treatments, consisting of sham surgery or injections of vehicle, 
phosphate buffered saline (PBS), respectively. For both groups, bilateral, full-field ERGs were 
recorded in dark-adapted (DA) birds (ONS: n=6; TTX: n=5) or in light-adapted (LA) birds (ONS: 
n=10; TTX: n=5) prior to the imposed treatment (at one day post-hatch) and on days 3-, 5-, 7-, 14-, 
and 21- post-treatment on the same birds. In addition, bilateral, full-field, long-flash (150 ms) ERGs 
were recorded from light-adapted birds (ONS: n=8; TTX: n=5) prior to treatment (at one day post-
hatch) and again at 3-, 14- and 21-days post-treatment. Interpolation and curve fitting, including Naka 
Rushton fitting, were used to report parameters of the ERG stimulus-response series such as 
maximum amplitudes (Vmax) and sensitivity (k, stimulus producing half Vmax). Cell counts (retinal 
histology) were conducted of the RGC and inner nuclear layers from histological sections of a 
separate group of 6 birds sacrificed at 21 days post-ONS.  
For both groups, the measures of the DA ERG stimulus-response series (dark-adapted Vmax and k, 
the oscillatory potential amplitudes, and the interpolated a-wave parameters) did not differ between 
the treated and sham-treated eyes in either treatment group. In addition, for both treatment groups, the 
negative waveform of the scotopic threshold response (STR), which reflects RGC function in most 
mammals, was not apparent in the chick ERGs to dim flashes. No differences between the eyes were 
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detected for the positive STR/DA b-wave to 0.01 cd.s/m2 flashes (ONS: p=0.59; TTX: p=0.21). 
Similarly, the photopic negative response (PhNR) following the light adapted b-wave was small and 
showed no effect of either treatment (ONS: p=0.92; TTX:  p=0.11). However, the offset positivity, 
the d-wave amplitude, was smaller in the treated eyes in both the ONS and TTX groups (ONS: 
p=0.008; TTX: p=0.03), but d-wave implicit times did not differ. Cell counts confirmed that RGCs 
were selectively lost following ONS (p<0.0001). 
This study suggests that the STR and PhNR do not reflect RGC functions in chickens, as they do in 
most mammals.  Anatomical differences between the chicken and human retinae might underlie 
differences in the generation of ERG waveforms associated with ganglion cells. In particular, chicken 
eyes, and avian eyes in general, lack an inner retinal blood supply and associated intra-retinal 
astroglia which may be necessary for the generation of STR and PhNR waveforms. Finally, this thesis 
showed that, unlike in humans, the chicken d-wave may reflect the function of cells in the optic nerve 
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1.1 Retinal anatomy and physiology  
This section reviews literature about the vertebrate retina and electroretinogram. This review takes the 
format of general knowledge across various species first, the human variation, and then the retina of 
the chicken (Gallus gallus domesticus).  
1.1.1 Vertebrate Retina  
The eye is considered as one of the most complex organs of the body. The eye can be divided into 
three layers: the outer, middle, and inner layers. The inner layer, the retina, is a complex, layered 
structure of neurons responsible for detecting light and vision. The middle layer is the vascular 
component of the eye, which is responsible for providing the majority of materials for the metabolic 
needs of the structures of the eye. This middle layer has the choroid, the ciliary body and the iris. The 
pupil size, which is controlled by the iris, is responsible for controlling the amount of light falling on 
the retina (Remington 2012). The outer layer, which is the protective layer of the eye, consists of the 
supporting sclera, which is continuous with transparent tissue at the front of the eye, and the cornea, 
through which most of the light rays coming to the eye are refracted (Remington 2012). The epithelial 
layer on the sclera around the cornea is the conjunctiva. 
The retina contains many types of neurons, including the photoreceptors, cones and rods, bipolar cells 
and retinal ganglion cells (RGCs) (Remington 2012). Other major classes of neurons are horizontal 
cells and amacrine cells.   
The internal limiting membrane is located at the innermost boundaries of the retina. The membrane is 
made of the inner end of the principal retinal glial cells, the Müller cells, and are also referred to as 
footplates of the Müller cells. The inner limiting membrane is smooth, and some modifications occur, 
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such as astrocytes replacement and inclusion of vitreous fibres at the optic disc and periphery, 
respectively (Remington 2012). The nerve fibre layer (NFL) runs parallel to the surface of the retina 
adjacent to the inner limiting membrane. In mammals, the NFL is made of unmyelinated axons of the 
retinal ganglion cells (RGCs) (Remington 2012), while in avians such as chickens, the RGC axons are 
myelinated by oligodendrocytes (Fu and Qiu 2001, Fischer et al. 2010). The appendages of Müller 
cells are found in the NFL where they cover/wrap around retinal vessels (such as the superficial 
capillary network in vascularized retinae) and nerve fibres (Oyster 1999). The next layer, the RGC 
layer, is usually one cell thick but might be 8-10 cells thick near the macula in primates (Remington 
2012). Some displaced amacrine cells, Müller cell bodies and astroglia cells might be found at this 
layer (Remington 2012).  
The next layer, the inner plexiform layer (IPL), contains the synapses of the RGCs and bipolar cells. 
Other synapses occur between these cells and amacrine cells. In vascularized retinae, the inner 
capillary networks of retinal vessels are in this layer (Remington 2012). The next more distal layer, 
the inner nuclear layer (INL), comprises the neuronal cell bodies of bipolar, amacrine, Müller 
horizontal and, uncommonly in mammals, displaced RGCs (Remington 2012). In the avian retina, 
displaced RGCs are common and have their cell bodies and dendrites in the IPL (Mey and Johann 
2001). These displaced RGCs have the most extensive dendrites, and their axons project into the 
accessory optic system of the avian brain (Mey and Johann 2001). Distal to the INL is the outer 
plexiform layer (OPL), which contains the synapses of the photoreceptors and bipolar cells (Zareen et 
al. 2011). Also, this layer has horizontal cell synapses. The outer nuclear layer, which consists of the 
cell bodies of photoreceptor cells, is next to the OPL (Oyster 1999). The external limiting membrane 
(ELM) is a membrane-like structure made up of the outer processes of the Müller cells surrounding 
the photoreceptor cells near the junction of their outer and inner segments. It has been suggested by 
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Panda-Jonas et al. (1996) that the external limiting membrane forms a barrier that prevents the 
movement of macromolecules from the photoreceptor layer to the inner part of the retina (Zareen et 
al. 2011). Distal to the outer limiting membrane, the photoreceptor outer segments form the 
photoreceptor layer of the retina.   
The types and composition of retinal cells depend on the species of the animal under study as the 
retina in most animals has adapted to the visual environment (Bowmaker and Knowles 1977). Light 
absorption and transduction functions are performed by photoreceptors, which are broadly classified 
into rods and cones. The photoreceptors absorb light by using visual pigments (chromophores) 
derived from Vitamin A. Isomerization of a chromophore upon light absorption results in the 
biochemical cascade of phototransduction, which eventually leads to the halting of glutamate 
neurotransmitter release.  
Rods are designed to capture photons at low light levels and, therefore, are more sensitive than cones 
and very useful for dim vision. Furthermore, the organization of the cones tends to be concentrated in 
a specific part of the retina to achieve better visual acuity (Oyster 1999). For humans, many primates 
and raptors depend on excellent visual acuity for survival, and these cones are concentrated at a 
specialized depressed (pit) part of the retina called the fovea (Oyster 1999). The chicken retina has a 
concentration of cones 2 mm dorsal to the optic disc but has no foveal pit (Morris 1982). Primates 
have three types of cones: long-wavelength sensitive (red light), medium-wavelength sensitive (green 
light) and short-wavelength sensitive (blue light) (Oyster 1999). However, avian species have 
additional photoreceptors in the ultraviolet range, and chickens specifically have five cone types, 
including the double cone (Kram et al. 2010, Wisely et al. 2017).  
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The photoreceptors synapse with the second-order neuron, the bipolar cells. One feature of the bipolar 
cells is that they initiate the parallel visual processing pathway in the visual system by dividing the 
pathway into on- and off-pathways (Famiglietti and Kolb 1976). The on-bipolar cells are depolarized 
when glutamate release is interrupted by phototransduction in the photoreceptors. Furthermore, 
because they possess excitatory kainate and α-amino-3hydroxy-5-methyl-4-isoxazole propionic acid 
(AMPA) receptors, they are also known as metabotropic glutamate receptors (mGluRs) (Sasaki and 
Kaneko 1996).  
Contrary to the on-bipolar cells, the off-bipolar cells have inhibitory glutamate receptors and are 
known to have ionotropic glutamate receptors (iGluRs). Another interesting feature of the bipolar 
cells is the segregation of the off-bipolar to RGC synapses from the on-bipolar to RGC synapses at 
the IPL, as shown in  Figure 1. Specifically, the off-bipolar cells synapse close to the INL, while the 
on-bipolar cells connect to the RGCs close to the RGC layer (Nelson and Connaughton 1995). 
Moreover, this segregation occurs only in mature retinae and is absent if the off-bipolar cells are 
blocked during early development. The segregation develops independently of the presence or 
absence of functioning RGCs (Tootle 1993, Chalupa and Gunhan 2004).   
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Figure 1: Segregation of off visual pathway (in blue) from the on pathway (in red) at the IPL. 
From Chalupa and Gunhan (2004) with permission.  
 
The primary retinal cells that transmit highly processed visual information to the brain are the RGCs. 
These third-order retinal cells are highly diverse. In terms of morphology, some possess small cell 
bodies but complex dendrites; others have large cell bodies but may have a smaller dendritic spread 
(Oyster 1999). Functionally, some fire impulses in response to motion, stimuli from specific direction 
or stimuli from particular orientation. The response to the stimuli can be sustained or transient. 
Moreover, the RGCs only respond to a specific range of contrast, stimulus size or colour (Oyster 
1999).   
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Embryologically, RGCs are the first to differentiate from primordial retinal stem cells (Cepko, 2014, 
Rapaport et al., 1996, Tian, 1995). It is known that upon migrating to the ganglion cell layer, RGCs 
extend their axons before forming extensive dendrites (Maslim et al. 1986, Kirby and Steineke 1991); 
segregation of the dendrites at the IPL is seen in matured RGCs as shown in Figure 2.   
  
Figure 2: The embryological development of RGCs across species. 
VS is the mitotic RGC stem cells. From Sernagor et al. (2001). with permission   
  
Müller cells are the primary glial cells in the retina and span the layers of the retina from the inner to 
the outer limiting membranes (Figure 3). They have close contact with most retinal cells (Pfrieger and 
Barres 1996) and serve to control the flow of oxygen, carbon dioxide, nutrients and other metabolites 
(Reichenbach and Robinson 1995).   
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Figure 3: A drawing of the retina cells and its layers, highlighting the role of the Müller cell. 
From Belecky-Adams et al. (2013) with permission.  
 
1.1.2 Relationship between astrocytes and Müller cells  
In the retina, the astrocytes and Müller cells seem to perform similar functions. Additionally, it has 
been postulated by Ramírez et al. (1998) and Jammalamadaka et al. (2015) that astrocytes 
complement the role of Müller cells in performing their functions. These two retinal glial cells store, 
 
8  
    
and release glycogen, help neurotransmitter metabolism, take up CO2, regulate potassium ions, and 
help establish the blood-retinal barriers. Although Müller cells are present and traverse all layers of 
the retina, the presence or distribution of astrocytes is complex. Whereas elongated astrocytes are 
found in the NFL of most vertebrates, the intra-retinal stellate (protoplasmic) astrocytes tend to be 
abundant only in animals with inner retinal blood vessels (Schnitzer 1988, Chojnacki and Weiss 
2008). In animals with avascular retinae, intra-retinal astrocytes are rare (Schnitzer 1988, Fischer et 
al. 2010). In chickens (Fischer et al. 2010), hippopotami and rhinoceri, all of which have avascular 
inner retina, the astrocytes are restricted to only the optic nerve head (optic disc) (Schnitzer 1987, 
Schnitzer 1988). In animals with vessels around the disc, the astrocytes are located around the optic 
disk. Moreover, in the rabbits’ partially vascularized retina, the astrocytes are located only around the 
vascular (medullary artery) part of the retina and are rare in the other parts of the retina (Clark and 
Mobbs 1992, Trivin et al. 1997, Haddad et al. 2001). Intra-retinal astrocytes are numerous in animals 
with inner retinal blood supply except in areas of the retina which have no vessels, such as the fovea 
(Stone and Dreher 1987, Jammalamadaka et al. 2015). The concept of the link between the astrocytes 
and inner retinal blood vessels has led to the assumption that the intra-retinal astrocytes are necessary 
for the development of inner retinal vessels, and for most vertebrates, the distribution of astrocytes is 
based on whether they have inner retinal blood vessels or not. Because of the close functional 
relationship of the Müller cells and the retinal astrocytes, in animals without inner blood vessels, 





    
1.2 Embryology of the human retina  
Following the formation of a hollow blastocyst and three germinal layers a neural tube forms by 
surface invagination the neural plate, which is derived from the primordial ectoderm.  At the rostral 
end of the developing embryo, the primitive vesicles of the developing brain, including the 
diencephalon (Oyster 1999). An outpouching of the diencephalon gives rise to the earliest stage of 
ocular development, the optic vesicles. The vesicles fold inwards to form the two-layered cup-shaped 
optic cups. Although the optic vesicle is initially located beside the surface ectoderm, a layer of 
derivative neural crest (mesenchymal) cells migrates between the optic cup and the ectoderm. Several 
eye structures, such as the choroid, the corneal endothelium, and the ciliary body, develop from these 
mesenchymal cells (Oyster 1999).  
The optic vesicle, on contacting the surface ectoderm, causes the surface ectoderm to thicken to form 
the primordial lens, and the invagination of the optic cup results in a groove called the choroidal 
fissure (Oyster 1999). The primitive central artery forms and grows into the optic cup through the 
choroidal fissure. Consequently, the two-layered optic cup forms the retina; the outer layer becomes 
the retinal pigmented epithelium (RPE) and the inner one results in the neural retina (Oyster 1999). In 
humans, this process takes place between 25 – 35 days of gestation, and in chicks is complete by 
about 20 days (Wisely et al. 2017). The Müller cells and the true astrocytes are both of the 
neuroectoderm origin (Ramírez et al. 1998) and the Müller cells may share the same stem cells as 
neurons.  In some species such as chickens, the Müller cells are progenitor cells for neurons (Ramírez 
et al. 1998). In humans, the astrocytes originate from the brain and enter the retina through the optic 
nerve in the 13th week of gestation (Jammalamadaka et al. 2015). Astrocytes follow the pathway of 




    
1.3 Chicken eye and retina  
The basic structure of the chicken retina is similar to that of other vertebrates (Hocking and 
Guggenheim 2014). In fact, most of the information about the vertebrate retinal structure and function 
were obtained through the study of the eyes of chickens (Bovolenta and Martinez-Morales 2019). 
However, there are notable differences, and these differences can be categorized as macro and micro 
levels. At the macro level, the chicken eye takes about 50% of the cranium space whilst the human 
eye is 5% of the human cranium (Waldvogel 1990). Differences in the anterior chicken eye compared 
with most mammals include the presence of ossicles at the limbus, the region between the sclera and 
cornea, and that the iris and ciliary body contain skeletal muscles, but the most substantial differences 
are in the retina. The inner retina of the chicken has no inner retinal vessels; instead, it possesses 
pecten oculi, which provides nourishment to inner retinal structures (Pettigrew et al. 1990).  
Moreover, 2 mm dorsal from the chicken optic disc (Morris 1982) is a no "pit" fovea called the area 
centralis (3mm in diameter), which performs similar functions as a fovea. The photoreceptors of the 
chicken retina have oil droplets (Figure 4), located between the outer and inner segments of the cone 
photoreceptors (Bowmaker and Knowles 1977). The oil droplets are pigmented, and the pigments 
filter light, which except for the double cones, contributes to colour vision (Hart and Vorobyev 2005). 
The oil droplets' pigmentation is modified by the type of feed (Meyer et al. 1971) given to the chicken 
(high carotenoid feeds lead to higher pigmentation), and by the light intensity (Hart et al. 2006) of the 
environment of the chicken (chickens reared in the high intensity of light have more pigmentation). 
Chickens have single cones with peak sensitivity to short, medium and long wavelengths as in 
humans but also an additional cone type that is sensitive to ultraviolet (UV) (Osorio et al. 1999). 
Furthermore, the chicken has double cones, which are sensitive to medium to long wavelengths 
(Morris and Shorey 1967).  
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In the inner retina, the AII amacrine cell, which mediate the rod pathway in humans and many other 
mammals, is reported to be lacking in the chicken retina (Shi and Stell 2013). Possibly, the AII 
amacrine cells is lacking because chickens are diurnal, and their retina is dominated by cones. 
Additionally, chickens have an enhanced centrifugal vision system (CVS), efferent fibres from the 
brain to the retina (Cowan et al. 1961, Gutierrez-Ibanez et al. 2012, Miles 1972), while such efferent 
fibres are rare in the primate retina (Gastinger et al. 2006). Most of the CVS fibres terminate close to 
the off-bipolar cells and excite RGCs (Lindstrom et al. 2010). This CVS is implicated in the feedback 
system, which plays an important role in the feeding habit of chickens. Since the synapses of the CVS 
cells are closer to the RGC layer of the chicken retina, it is expected that off-pathway may play an 
important role in influencing the ERGs of RGCs of chickens. For instance, in toads and salamanders, 
also animals with enhanced CVS, dysfunctional RGCs influenced the electroretinogram of their off-
pathway. In chickens, sectioning of the CVS only has the same effect on refractive error as full optic 





    
  
Figure 4: Chick photoreceptor cells showing the oil droplet. 
RPE is retinal pigmented epithelium, ONL (outer nuclear layer), LWS (long wave sensitive), RH2 
(rod-opsin-like cone opsin), short wavelength sensitive (SWS).  Adapted from Wisely et al. (2017), 
with permission. 
  
At the microlevel, chickens, like other vertebrates with avascular inner retinae, such as guinea pigs 
and other birds, have no or very few intra-retinal astrocytes. Unlike other vertebrates, chickens have 
oligodendrocytes surrounding the nerve fibres (Fischer et al. 2010). Additionally, the chicken 
possesses non-neuronal intra-retinal non-astrocytic inner retinal cells (NIRGs) (Zelinka et al. 2012). It 
has been suggested by Fischer et al. (2010) that these NIRG cells play a role in Müller cell and 
neuronal retina cell survival.   
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1.4 Models of RGC damage    
Surgical excision of the optic nerve (optic nerve sectioning; ONS) or intravitreal injection of 
tetrodotoxin are employed as methods to destroy or block RGC function, respectively (Wildsoet and 
Wallman 1995, Chong 2013).  Chong et al. (2013) and Choh et al. (2004) showed that ONS of 
chicken eyes causes a significant and progressive loss of the number of RGC cells starting from days 
three post-surgery. This finding makes ONS a particularly excellent model choice for studying RGC 
deficits as it allows longitudinal observation of the effect of progressive reduction of RGC numbers. 
The RGC reduction is mediated by apoptotic processes (Choh et al. 2004, Chong et al. 2013).   
Tetrodotoxin is a neurotoxin that blocks action potentials in neurons with axons by blocking the 
voltage-gated sodium channel (Nav) (Narahashi 1974). TTX is, therefore, effective in inhibiting the 
RGCs and spiking amacrine cells. Because the affinity of the TTX to a particular Nav depends on the 
composition of the channels' amino acid isoforms, and different species have different amino acid 
isoforms in their Navs, some species are resistant to the effect of TTX (Catterall et al. 2005). Out of 
the 10 types of Navs, TTX has a high affinity for Nav 1.4, and Nav 1.6, which frequently are 
associated with the neurons in the CNS, including the chicken retina (Lee and Ruben 2008). The TTX 
effect in the retina is reversible. Intravitreal injection of 0.8 µg in 8 µl citrate buffer is known to 
effectively stop the function of the RGC in domestic chicken eyes (Wildsoet and Wallman 1995) for 




    
1.5 Electroretinograms (ERGs) 
The activity of retinal neurons in the form of the electrical response of the retina to light flashes can 
be recorded from the surface of the cornea.  This non-invasive method of assessing retinal cell 
function has become an essential tool for studying the retina in clinical and laboratory settings 
(McCulloch et al. 2015).   
Generally, it is widely accepted that retinal responses such as ERGs occur due to voltage changes 
generated by inward and outward ion flow from the changes to localized conductance across the 
active retinal cell membranes (Brown 1968, Frishman 2006). These voltage changes cause currents to 
flow through the extracellular space, following the potential gradients. Part of the active cell 
membrane serves as a generating source of these currents or as a sink, and these currents are directed 
towards a less active part of the membrane. Therefore, the aggregate effect of many cells generating 
the extracellular current flowing in the same vector direction synchronously results in potential 
changes referred to as field potentials (Brown 1968, Frishman 2006, Perlman 2015). The 
measurement of the field potential can be recorded on the eye surface if the field potential is radiating 
outward around the eye. Most retinal neurons are involved in the generation of ERGs (Frishman 
2006). Based on the influence of specific factors, such as the position and orientation of the cell, and 
the relative strength of the cellular responses, the ERG waveforms generated can be attributed to 
specific types of retinal cells. Mainly, radially oriented retinal cells generate most ERG signals 
(Brown 1968, Frishman 2006, Perlman 2015). Therefore, photoreceptor cells, bipolar cells and Müller 
glial cells are the dominant generators of ERGs. Conversely, the small to undetectable signals 
originating from specific retinal cells that are not radially oriented, such as amacrine and horizontal 
cells are associated with much smaller field potentials such as the oscillatory potentials that are 
superimposed on the leading edge of b-waves.  The current dipole, created as a result of the 
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movement of current from the generating area to the receiving area (current sink) of radially oriented 
cells, flows mostly intraretinally. A small amount of the current generated by the dipoles flows 
through tissue external to the retina, i.e., through the vitreous and the highly resistant RPE, and 
returns to the neural retina (Brown 1968, Frishman 2006, Perlman 2015). From the above 
explanation, it stands to reason that placement of the active electrode has a considerable influence on 
the magnitude of ERGs. Other factors, such as the background illumination, the adaptation of the 
retinal cells to the light stimulus, the strength of the flash stimulus, and the stimulus wavelength, 
affect the relative contribution of the cells to the ERGs (Frishman 2006). For instance, in light-
adapted ERGs, most rods are suppressed and hence have little contribution from rod photoreceptor 
cells (Frishman 2006).   
Using drug neuro-active drugs, research studies have made significant contributions to understand the 
ERG waveform. Ragnar Granit won the Nobel prize for medicine for his research in sensory 
physiology, including his studies of ERGs. His classic work, published in 1933, showed that ERGs 
have three components, which he named the PI, PII, and PIII, in order of their loss when exposed to 
anesthesia (Granit 1933), as shown in Figure 5.  
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Figure 5: A representation of Granit's view of the components of the long-flash ERGs. Adapted 
from (Perlman 2015) with permission.   
Before Granit’s dissection of the ERG components, several researchers, including Holmgren and 
Armington, made major contributions to the detection and our understanding of ERGs (Perlman 
2015). Einthoven and Jolly discovered the a-wave and b-wave components of ERGs (Einthoven and 
Jolly 1908). The use of drugs to inhibit specific cell types of the retina, thus studying the uninhibited 
part, is termed pharmacological dissection, and this method has contributed greatly to understanding 
the sources of ERG waveforms. Additionally, the use of intra-retinal electrophysiological recordings 
also contributed immensely to our understanding of the source of the ERGs (Perlman 2015). Since the 
discovery of the pharmacological agent, L-aspartate, which can isolate the function of the 
photoreceptors, it has been found that photoreceptors are the source of a-wave (Perlman 2015).  
Because of the proximity of the potassium sink of the Müller cells and the bipolar cells, the studies to 
determine the source of b-wave were quite controversial. The Müller cells were initially thought to be 
the source of b-wave (Miller and Dowling 1970). However, intra-retinal recording and 
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pharmacological dissection of the retina revealed that the ON bipolar cells are the major generators of 
b-waves. In definitive studies, Lei and Perlman (1999) used barium ion salt, which specifically blocks 
the function of the Müller cell, to show that b-waves originate from bipolar cells. In their study, 
although Müller cell function was blocked, there was an enhancement of the b-wave.   
1.5.1 Brief-flash ERGs  
In humans, brief flash ERGs are widely used as retinal function tests (McCulloch et al. 2015), 
possibly because testing is easily performed clinically and has been standardized by the International 
Society for Clinical Electrophysiology of Vision (ISCEV). The ISCEV standard for full-field ERG 
testing includes the DA ERG amplitudes in response to 0.01 cd.s/m2 stimuli  (DA b-wave) to assess 
rod pathway function, dark-adapted 3 cd.s/m2 flashes for both rod and cone driven retinal function, 
dark-adapted 10 cd.s/m2 flashes for enhanced a-waves to evaluate photoreceptor function, dark-
adapted oscillatory potentials (OPs) to reflect middle retinal cells, light-adapted 3 cd.s/m2 flashes and 
light-adapted 30 Hz flicker ERG to study the cone-driven retinal pathway (McCulloch et al. 2015). 
For light flashes below the human psychophysical threshold, negative and positive ERG waveforms 
are observed on the human dark-adapted ERG (Frishman et al. 1996). This waveform is called the 
scotopic threshold response (STR), the negative and positive STR (nSTR and pSTR), respectively. 
These STRs are distinguished from a- or b-waves because they are removed with pharmacological 
agents that block inner retinal cells, and because the STR is elicited with very weak flashes below the 
perceptual threshold. In macaque monkeys, pSTRs are small because part of their waveforms are 
negated by nSTR (Frishman et al. 1996). The STR waveforms are easily elicited in rod-dominant 
mammals such as rodents and in non-human primates. However, these STRs are not universally 
present in all vertebrate dark-adapted retinae.  
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1.5.2 Diagnostic potential of brief ERGs to measure optic nerve or RGC deficit  
Whereas it is relatively easy to test for the function of radially oriented retinal neurons such as 
photoreceptor cells (a-waves) and bipolar cells (b-waves), non-invasive testing of the RGC function is 
more challenging (Frishman 2006, Perlman 2015). However, in humans, the STR, photopic negative 
response (PhNR), and pattern reversal ERG (PERG) protocols reflect RGC function (Viswanathan et 
al. 1999, Frishman 2006, Perlman 2015). As described above, the STRs are dark-adapted ERGs 
elicited by very weak flashing (-6 to -3 log cd.s/m2) stimuli; the PhNR is the negative potential that 
follows the b-wave in light-adapted ERGs, whilst the PERG is generated through contrast changes 
such as alternating checkerboard stimuli.  
While standard ERGs are useful to test retinal function, they provide limited usefulness in the 
detection of RGC deficits. The PERG is the most studied ERG known to objectively assess the 
central vision of primates. Standard PERGs are elicited using checkerboard stimuli and require clear 
ocular media and refraction. The PERG is made of two main waveforms, P50 and N95. The P50 
waveform reflects macular function, and the N95 waveform originates from RGCs. In several 
mammals, PERG waveforms are reduced on intravitreal injection of TTX (Viswanathan et al. 2000) 
or ONS surgery (Harrison et al. 1987).   
In humans (Morny et al. 2015, Joshi et al. 2017), monkeys (Wilsey et al. 2017) and dogs (Takada et 
al. 2017), PhNRs hold great potential for diagnosis of RGC deficits. First described by Viswanathan 
et al. (1999), the PhNR has been useful for the detection of RGC deficits in that it has become a 
useful substitute to PERG in the study of RGC function. Additionally, the PhNR has the added 
advantage of not requiring clear and optimal correction of refractive error of subjects. Clinically, 
studies indicate that PhNR amplitudes are sensitive to RGC cell functions (Morny et al. 2015, Wilsey 
and Fortune 2016, Frishman et al. 2018); however, other studies point to the fact that the amplitude is 
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sensitive to the integrity of glial cells around the RGC layer of the retina (Machida et al. 2008, Raz-
Prag et al. 2010). Animals with inner retinal vascular supplies tend to have many glial cells, notably 
intra-retinal astrocytes and Müller cells, and these animals are also reported to have PhNRs reflecting 
RGC functions; it stands to reason that the PhNR may indirectly reflect RGC function but be 
generated by glial cells. Animals with avascular inner retina could help to differentiate the RGC from 
the glial origins of the PhNR.   
1.5.3 Long-flash ERGs  
ERGs elicited by long-duration (150-200 ms) stimuli in the presence of rod suppressing backgrounds 
are useful for obtaining ERGs from on- and off- retinal pathways. D-waves are positive responses to 
the flash offset, while onset responses are indicated by a- and b-waves. The stimulus strength and 
duration affect the amplitudes obtained in long-flash ERGs. Sustar et al. (2006), showed that the 
optimal offset d-wave is obtained with flashes 150 to 200 ms; shorter flash durations result in 
incomplete separation of the on- and off responses, showing an i-wave, superimposed on the onset b-
wave rather than a separated d-wave at off-set. Also, the longer the duration of the stimuli, the larger 
the amplitude of the d-wave. The amplitudes of the b- and d-waves also depend on the stimulus 
strength in a non-linear manner (Al Abdlseaed et al. 2010).  
ISCEV recently published an extended protocol for long-flash ERG recordings with a white stimulus 
of 150-350 cd/m2 for eliciting the onset ERG and off-set d-wave (Sustar et al. 2018). However, 
several studies point to the use of other wavelengths such as orange on a green background to 
selectively stimulate the L and M-cones (Sustar et al. 2006). Evers and Gouras (1986) and Sustar et 
al. (2006) report that a long-wavelength flash stimulus generates significantly smaller d-wave 
amplitudes; hence long wavelength stimuli should not be used to elicit the off-set responses. 
However, published work still makes use of long-wavelength flashes to successfully elicit d-waves 
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(Morny et al. 2015, Morny et al. 2019). Furthermore, due to significant interspecies differences in 
retinal constituents, the long-flash ERG protocol is expected to be specific to the species.  
Seiving et al. 1993 pioneered work in the long-flash ERGs in primates, describing the on-response of 
the ERG as being a typical biphasic waveform, as seen in short flash ERGs. The second component, 
the d-wave, is typically a positive off-response. It has subsequently been suggested that the positive 
off-response is not universal and is found selectively in vertebrates with significant cone 
photoreceptors (Lei, 2003). Therefore, vertebrates with retinae containing a substantial population of 
cones such as primates, birds and guinea pigs tend to have a positive polarity of the d-wave, while 
retinae with fewer number of cones, such as those in rats, typically show a negative-going waveform 
after offset. Furthermore, there seems to be a positive relationship between the number of cones and 
the magnitude of the d-wave. It has been suggested that the on a-wave reflects the functions of 
photoreceptors with some contribution from hyperpolarizing bipolar cells (Bush and Sieving 1994) 
while the on b-wave reflects functions of the depolarizing on-bipolar cells with some contribution 
from the horizontal cells (Sieving et al. 1994). In contrast, the d-wave appears to reflect the off-
pathway with a major contribution from the hyperpolarizing off-bipolar cells, which are cone-specific 
with no direct connection to rod photoreceptors (Sieving et al. 1994). Additionally, Seiving et al. 
(1994), in proposing the ‘push and pull” model of brief-flash b-wave amplitude, showed that the 
amplitude of the brief-flash b-wave is influenced by increased (“push”) of the flash onset b-wave 
from depolarizing on-bipolar cells and decreased (“pull”) amplitude of the offset d-wave from the 
hyperpolarizing (off) bipolar cells.  
1.5.4 Development of chick electroretinogram  
The a-wave and b-wave onset are known to be recordable in chickens from pre-hatch day 18 of 
incubation (Ookawa 1971). Ookawa (1971), also noted that the a- and b-wave amplitudes increase up 
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to day 14 post-hatch. However, in the post-hatch chick, there is a notable drop in amplitude of the a- 
and b-wave on day seven post-hatch (Ookawa 1971).  
Moreover, the b-wave is most affected by a decrease in chicken body temperature far more than the a-
wave. This phenomenon is contrary to what is expected, as the a-wave, having its source from 
photoreceptors, should be more affected because it is closer to the systemic blood supply through the 
choroid (Ookawa and Tateishi 1970). Chick b-wave latencies are the same as the evoked potential of 
the optic tectum in Rhode Island chickens (Crampton and Boggs 1959).   
Furthermore, chicken oscillatory potentials (OPs) are thought to originate from inhibitory feedback 
pathways in the inner retina (Wachtmeister 1998) and are similar to human OPs (Yonemura et al. 
1963). However, Li et al. (1992) showed that, unlike human OPs, 6-hydroxy dopamine (6-OHDA), 
causes an increase in chicken OP amplitudes but reduced a- and b-wave amplitudes. 
Interocular differences in ERGs are common. Inter-ocular differences in ERG parameters have been 
explored in humans and primates with normal differences noted to be ±13% (Rotenstreich et al. 
2003), ±30% (Viswanathanm et al. 1999), respectively. McGoogan et al. 2000, demonstrated that 
chickens' ERGs are prone to volume conduction of the field potentials such that ERGs could be 
recorded at the untested contralateral eye (ERG crosstalk). To account for inter-ocular differences, 
Armstrong (2013) suggested that in a situation where both eyes (treated and fellow control eyes) are 




    
Chapter 2 
Introduction 
2.1 Retinal Ganglion Cells (RGCs) in disease 
Retinal cells, like all neural cells in the central nervous system, do not regenerate. Most human 
blinding diseases are results of photoreceptor or RGC dysfunction. Moreover, conditions associated 
with RGC dysfunctional conditions in humans are not reversible. Of these conditions, glaucoma is 
most prevalent globally (Pascolini et al. 2004). Also, other conditions with RGC dysfunction, such as 
optic nerve hypoplasia (ONH), are important for childhood blindness ((Rahi et al. 2003, Garcia-Filion 
and Borchert 2013). Therefore, the contribution of RGC functional measurement is important. 
Moreover, since these conditions cannot be cured, studies to inform the prevention of RGC 
dysfunctions are very relevant. More importantly, early diagnosis of these conditions is vital to 
management, prevention from further deterioration and/or cure. One aspect of early detection of 
RGCs dysfunction is the in vivo electroretinogram (ERG). ERG tests are non-invasive and are known 
to detect retinal dysfunction before structural damage is detectible.  
2.2 Animal models of the retina   
Several animal models exist for the study of RGC functions. Mostly these models use mammals such 
as cats, rodents, and non-human primates. The macaque monkey is frequently used because its retina 
is closest to humans (Viswanathan et al. 1999). However, primates are very expensive to maintain, 
and usually, few are available for research, thereby reducing the power needed for statistical analysis. 
Additionally, they are not easily amenable to genetic manipulation. Rodents are the most abundant 
animal model for RGC function studies. However, rodents have fewer cones and, in general, have 
retinae that are more suited for nocturnal vision. Chickens are inexpensive to acquire and maintain, 
have good visual acuity, and are diurnal. Also, the chicken has an avascular inner retina, which 
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eliminates ischemia as a confounding factor in RGC retinal research. Although there are anatomical 
differences in the retina of chickens and humans (Section 1.3), the spectral sensitivity of the chicken 
retina and the origin of ERG waveforms associated with glial cells might be expected to differ from 
that of humans. However, surprisingly, but for the UV cones, the spectral sensitivity of chick vision 
closely matches that of humans. ERG protocols with no UV stimulation (i.e. wavelengths above 420 
nm) are well-matched to the human relative spectral sensitivity (Li et al., 1992, Schnapf et al., 1987) 
Several studies of the structure (retinal histology) and function (PERG, PhNR and STR) of RGCs 
exist for non-human primates and rodents (Frishman et al. 2000, Bui and Fortune 2004, Porciatti 
2015), but similar studies in chickens are rare. Ostrin et al. (2016) showed that it is possible to record 
PERGs in chickens but conclusively demonstrated that the PERG waveforms do not reflect RGC 
function. Petersen-Jones et al. (2010) suggested that d-waves reflect the non-spiking RGC function in 
white leghorn chicks.   
Although a chicken's retina is cone-dominated and therefore perhaps ideal for isolating PhNRs and d-
waves, a literature search showed a paucity of data relating flash ERGs to RGC function in chickens.  
2.3 Objectives 
This project ultimately seeks to determine the effects of ganglion cell death and dysfunction, using 
ONS and pharmacologic blockade with TTX, respectively, on the flash ERGs in chickens using 
PhNR, STR and photopic long-flash ERG protocols; specifically, it is hypothesized that ONS will 
cause selective reduction of PhNR and STR waveforms in the ERGs of maturing chicks and that 
intravitreal injection of TTX will cause selective reduction of the PhNR and the STR in the ERG 
waveforms recorded from the retinae of maturing chicks.  In addition, it is expected that there will be 
a selective reduction of RGC in retinal histological cell count in ONS eyes. 
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2.3.1 Specific aims:  
These studies aim to develop the chick model for RGC development and function.  
Specifically:    
1. To monitor the time course of development of light- and dark-adapted ERG luminance-
response functions in the chick from hatching to 21 days post-treatment.   
2. To determine the effect of ONS on light- and dark-adapted ERG waveforms in the maturing 
chick retina.  
3. To determine the effect of TTX on light- and dark-adapted ERG waveforms in the maturing 
chick retina.  
4. To determine the effect of ONS on long-flash ERG waveforms in the maturing chick  




    
Chapter 3 
Materials and Methods 
3.1 Introduction 
This chapter describes the procedures used in the studies reported in this thesis, including procedures 
for inducing RGC degeneration (ONS) and pharmacological blockade of the RGCs.  In addition, the 
procedures and protocols for the evaluation of retinal function (ERGs) are included. The procedures 
which are common to all study subjects are described in this chapter. 
3.2 Animal protocols 
All research undertaken in this thesis adhered to the standards of the Canadian Council on Animal 
Care. Ethical approval for the study was obtained from the Animal Care Committee of the University 
of Waterloo. Gallus gallus domesticus (White Leghorn chicken) mixed, unsexed hatchlings were 
purchased from Maple Leaf Poultry Foods Inc, New Hamburg, ON, Canada, for the study. The 
chickens were fed ad libitum with feed obtained from Jones Feed Mills Ltd, Mitchell, ON, Canada. 
All chicks that were 0 to 13 days old were housed in 1 meter by 1 meter heated stainless steel 
brooders, and floor housing was provided for 14 to 21 day-old chicks. The housing for the chicks was 
kept at room temperature of the building. The chicks were kept on a 12h light and 12h dark cycle 
throughout all studies. Both retinal dysfunction studies were initiated when chicks were 1-day old 
(day 0 of the experiment). 
3.3 Protocol to induce RGC dysfunction: optic nerve section (ONS) 
Each chick (n=18) was anesthetized with 2% isoflurane prior to and during optic nerve section (ONS) 
surgery. For each eye, the skin lateral to the lateral canthus was wiped with sterile alcohol pads. At 
the anterio-lateral orbital bone of the chick, a 4 mm vertical cut was made on the skin. Another 
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incision was made to the underlying fascial sheath. The eyeball was held away from the temporal 
orbital wall by the aid of forceps to expose the optic nerve. The exposed sheath covering the nerve 
was poked into using a small (3 mm) knife, and the forceps were used to enlarge the hole to expose 
the nerve fibers. Forceps were used to break the nerve fibers by pulling them upwards. To ensure all 
the fibers had been cut off, the hole was visualized, and any fiber left uncut was excised.  
The contralateral eye was treated to the same procedures as above, but the nerve fibers were not cut 
(sham surgery). The eye designated as the treated or control eye alternated between groups, such that 
if the right eyes of all chicks in a group for surgery were chosen as the treated eyes, the left eyes of 
the next group of chicks for surgery would be chosen as the treated eyes.  
3.4 Protocols to induce RGC dysfunction: intravitreal injection of tetrodotoxin 
A different set of chicks (n= 14) were used for the tetrodotoxin (TTX) intravitreal injection 
procedure. Each chick was anesthetized as described above.  Then, using a Hamilton syringe, 10 µl of 
phosphate buffer solution (PBS) containing 1.0 µg of TTX was injected into the vitreous of the 
treated eye. A preliminary experiment showed that this concentration (0.1 µg/ul) of TTX causes the 
desired blockade in each age group of the chicks.  The contralateral sham eye was intravitreally 
injected with 10 µl of the PBS vehicle only. The injections were repeated 1 hour before every ERG 
procedure.  
3.5 Verification of optic nerve / RGC dysfunction 
To ascertain whether the optic nerve section procedure was successful, each bird’s pupillary reaction 
were tested (one eye at a time) a day before ERG testing for the ONS group. Pupils were tested one 
hour after injection for birds in the TTX group. The bird was restrained, and its beak placed on a head 
holder whilst a custom-made lid retractor was used to open the eyelid. The left eye was patched with 
 
27  
    
a black electrical tape. A pen torch was then switched on to elicit the pupillary test on the right eye. 
The light was directed to the center of the pupil. The pupillary response was then noted. The pupillary 
reaction of the left eye was similarly tested with the right eye patched. The pupillary test is known to 
be an effective indicator of whether ONS treatments (McBrien et al., 1995, Wildsoet and Wallman, 
1995, Wong-Riley et al., 1989a) or TTX treatments on the eye (Wildsoet and Wallman 1995) were 
successful,  indicated by fixed dilated pupils when stimulating the treated eyes, and light-induced 
pupillary constriction in the control eyes.   
To further confirm the success the optic nerve dysfunction procedure, each chicken for this study 
went through visual tracking testing. Each bird was restrained with their heads allowed to move freely 
and placed on a stage with the untested eye occluded. The chicken was then presented at the central 
view with the OKN Strips IOS application on an Iphone 6 (Apple, Cupertino, USA), which produced 
a moving 0.2 cpd (cycle per degree) white and 100% black square wave grating placed 5 cm away 
from the chicken eyes. The stripes moved nasal to temporal first and from temporal to nasal. The 
success of the treatment procedure is indicated by the absence of visual tracking of the chicken in the 
treated (dysfunction) eye and the presence of the tracking movement in the sham (control) eye. In all 
cases, the ONS/TTX injections were successful. 
3.6 Chicken retinal histology procedure 
Six chickens were used for histological analyses (6 optic nerve-sectioned eyes and their contralateral 
sham eyes). The ONS and sham procedure was as described in Section 3.3.  The enucleated eyes were 
cut at the ora serrata. The vitreous and the anterior portion were removed, leaving the posterior eye 
cup.  The eye cup was fixed in 4% paraformaldehyde (w/v) with 3% sucrose (w/v) in 0.1M 
Sorensen’s sodium buffer (23.996 g/L NaH2PO4, 23.392 g/L Na2HPO4  in deionised water; pH of 7.5) 
for 20 mins. The tissue was then washed in 0.1M Sorensen’s buffer for 5 min. The washing was 
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repeated for 3x and the eyecup was then cryoprotected in 30% sucrose (w/v) in 0.1M Sorensen’s 
buffer for 12 hrs. Optimal cutting medium (VWR CA27900-2460) was used to embed the eyecups in 
22 mm by 22 mm molds, before freezing. The eye cups were sectioned at 12 µm using a cryotome 
(Leica CM 1900 UV). The sections were mounted on Superfrost™ Plus glass slides (VWR CA 
CA48311-703) and air-dried before being stored in a -20°C freezer. 
Only tissue from the central retina was used for the histological staining. After washing with PBS (3x 
in 5 minutes), slides were stained with 4’,6-diamidino-2-phenylindole (DAPI; 1M, 5 min; Invitrogen, 
Walthon, MA, USA) to label the retinal cell nuclei.   Slides were mounted with antifading mountant 
and a cover slip before viewing under a microscope. 
3.6.1 Microscopic Imaging, and histology analyses. 
An upright fluorescence deconvolution microscope (Zeiss Axio Image.Z2) was used to capture the 
microscope images.  The image of the chicken central region of the retina was taken at 20x 
magnification.  The total number of cells at GCL layers was counted across the retinal image length. 
Cells within one cell diameter away from the GCL were counted. For the INL,100 µm wide 
rectangular boxes containing the entire INL height were superimposed on each image, and all cells 
located in or touching the box were counted.  
The cells were counted three times and averaged. The averaged cell count from the treated and 
control eyes were statistically analyzed with paired t-test. P ≤ 0.05 was considered statistically 
significant. 
3.7  Measurement of visual function: Electroretinograms (ERGs)  
For both the ONS and TTX groups, ERGs were recorded on day 0, prior to any treatment, then again 
3, 5, 7, 10 and 21 days after the day 0 recording. To anesthetize the chick cornea, one drop of 
proparacaine (Alcon Inc., Mississauga, ON, Canada) was applied to each cornea. After 1 minute, one 
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drop of vecuronium bromide mixture (VB) was applied to the cornea to dilate the chick’s pupil. The 
contents of the VB were 3 mg/ml of vecuronium bromide (Sigma-Aldrich, Oakville, ON, Canada), 
1% methylcellulose (Sigma-Aldrich, Oakville, ON, Canada), and 0.13% benzalkonium chloride 
(Sigma-Aldrich, Oakville, ON, Canada). One drop of VB was applied every minute for a total of four 
drops in each eye. The chick was then injected with a combination of ketamine/xylazine (53.3 mg/kg 
and 5.3 mg/kg, respectively).  
After anesthesia induction (no movement upon prodding), the chick’s head was placed in a head-
holder that was attached to a heated platform.  A sterile lubricant, Cellulvisc (Allergan Inc., Irvine, 
CA, USA), was applied to a temperature probe which was placed in the bird's rectum to monitor the 
well-being of the bird. The back of the head was wiped with a sterile alcohol pad. Two platinum 
needle reference electrodes (Diagnosys LLC., Lowell, MA, USA), one for each eye, were inserted 
under the skin of swabbed areas 3 mm from the lateral eye canthus of each eye. Eyelids were kept 
open with custom-made lid retractors. To keep the cornea moist, one lubricating drop of Celluvisc 
was placed on each cornea before placing a custom-made loop electrode on the cornea.  
The light stimulation and ERG recording system used in this study was an Espion E2 with AC 
amplifier (Diagnosys LLC., Lowell, MA, USA). The light was delivered through two mini-ganzfeld 
stimulators (Espion ColorBurst units, Diagnosys LLC., Lowell, MA, USA). The ganzfeld stimulators 
were placed such that eyes were equally illuminated. For each eye, the ganzfeld was consistently 
placed such that the eye of the chick was at the center, and the plane of the opening was parallel to the 
surface of the chick’s eye. ERGs for the treated eyes and the control eyes were tested simultaneously 
in each bird to avoid confounding effects, such as anesthesia (Choh et al., 2017) on ERG variability 
from sequential testing.  
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3.8 Stimulus protocols for ERG studies  
3.8.1 Dark-adapted ERG stimulus-response series  
Full-field, dark-adapted ERGs were recorded bilaterally. All dark-adapted ERGs were recorded in the 
night-time to activate the chicken rods (Schaeffel et al. 1991). Before the ERG recordings, the chick 
was dark-adapted for an additional 20 min to negate any effect of the dim red illumination. Each 
dark-adapted ERG was recorded for 500 ms after the flash, with a 50 ms pre-trigger, and a sampling 
frequency of 1000 Hz with a band pass of 0.1 to 1000 Hz. The stimulus was a 4 ms full-field white 
flash on dark background. White flash was generated using the three sets of narrow band light-
emitting diodes (LEDs) incorporated in Colorburst® mini ganzfeld stimulators. The central 
wavelengths of the LEDs were 650 nm (red), 588 nm (Green), 524 nm (amber) and 470 nm (blue), 
respectively, and the equivalent colour temperature of the white stimulus was 6500°K.  
Following a no-stimulus baseline measure, flash stimuli were incremented in 0.25 log unit steps from 
-5.25 log cd.s/m2 to the maximum available stimulus of +1.50 log cd.s/m2 (Table 1). All 
measurements, regardless of adaptation state, are expressed in photopic units as is conventional in 
clinical electrophysiology (McCulloch and Hamilton, 2010, McCulloch et al. 2015). 
The dark-adapted ERG parameters measured were the amplitudes and implicit times of nSTR, pSTR, 
a- and b-waves. Implicit times were measured to the maximum or minimum of the peaks or troughs, 
and amplitudes were either from baseline or peak to peak described in Table 1. Oscillatory potentials 
were simultaneously isolated from the dark-adapted ERGs to 3.0 cd.s/m2 stimuli. A separate channel 
with a band pass frequency filter of 50-300 Hz was used to isolate the OPs, as done in a similar study 
in chicken flash ERGs (Ostrin et al. 2016).  
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Measurement of Amplitude  
1  No ERG  NA No flash  No 
parameters  
20-30   
2-11  Scotopic  
Threshold  
Responses  
0.25  -5.25 to -3.0 
log   






0.25  -2.25 to -




10-20 From the  to the peak of the 





0.5  -1.25 to 
+1.5 log  
 
a-, b-waves 
and OPs  
3-6 a-wave: from the trough to 
baseline  
b-wave: from the trough of a-
wave to the peak of b-wave 
 
OPs: RMS between 5 to 55 ms  
  
3.8.2 Light-adapted ERG stimulus-response series  
For the light-adapted ERG protocols, the dilated eyes were light-adapted to 30 cd/m2 white light for 
10 minutes using the mini ganzfeld stimulators. Full-field, light-adapted, ERGs were recorded 
simultaneously from both eyes to 4 ms long-wavelength (red) flashes (LED with peak λ = 650 nm) in 
increasing flash luminance from 0.1 to 8 cd.s/m² on a rod suppressing short-wavelength (blue) 
background (LED peak λ = 462 nm) of 30 cd/m2. Table 2 shows the stimulus parameters. Each ERG 
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was recorded from a pre-triggered baseline of 50 ms to 500 ms after the flash, with a sampling 
frequency of 1000 Hz. An in-built analogue 60 Hz notch filter from the ERG system was used to 
reduce line frequency noise. Each step of the ERG protocol had at least 4 flash stimulus sweeps, 
which were then averaged as one result. For weak stimuli, up to 10 flashes were averaged to 
determine whether a detectable ERG was present.  
Table 2: The stimulus parameters and ERG waveform measures for the light-adapted ERG 
luminance-response series.  
Step 
range  










Measurement of Amplitude  






≥5  -0.1 to 0.75 in log 





a-wave: from trough to 
baseline 
b-wave: from a-wave 
trough to peak the of b-
wave  
PhNR: from the trough of  
PhNR to the peak of b-wave 
 
The parameters measured for this light-adapted ERG protocol were a-wave, b-wave, and PhNR. The 
Espion E2 software (Diagnosys LLC., Lowell, MA, USA) was set to autodetect the trough of the a-
wave, PhNR, and the peak of the b-wave based on maximum and minimum points in pre-selected 
post-stimulus time ranges. These were manually adjusted after reviewing the ERG waveforms and 
deleting any sweep contaminated by artifact. The amplitude of the a-wave was measured from the 
baseline to trough of a-wave, the b-wave from the trough of the a-wave to the b-wave peak and the 
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PhNR was measured from the peak of the b-wave to the trough of the PhNR. The implicit time of all 
the parameters was measured from the mid-point of the stimulus flash to the peak of the ERG wave. 
The amplitude and implicit time of the ERG parameters were then exported as Microsoft Excel files 
(Richmond, Washington, USA) for statistical analysis.   
3.8.3 Long-flash ERGs   
Full-field, long-flash (150 ms) ERGs were recorded bilaterally. The filters, sampling frequency and 
the pre-trigger and post-trigger times were matched to the protocol for recording the light-adapted 
ERG stimulus-response function (section 3.8.2). However, the long-flash duration and luminance 
matched those of the ISCEV extended protocol (250 cd/m2 flashes on 30 cd/m2 background), but the 
wavelengths determined in pilot study 2 (section 4.2) were used. The parameters measured were onset 
a- and b-waves, and offset d-waves. The responses to at least 5-10 long-flash stimuli were averaged 
and analyzed. The bilateral ERGs were recorded on day 0 (baseline, no treatment) and again on days 
3, 5, 7, 14 and 21 post-baselines for the ONS (8 birds) and TTX (5 birds) groups on day 0 and again 
on days 3, 14 and 21 post-baselines.   
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The amplitude and implicit time of the onset a- and b-waves were analyzed as above (section 3.8.2, 
Table 2), and the offset d-wave amplitude was measured relative from the offset point (at 150 ms) to 
the peak of the d-wave onset as shown in Figure 6.  
 
 
Figure 6: Chicken long-flash ERGs, showing how the d-wave amplitude parameters were 
measured. d, denotes the measurement of the amplitude from the off-set point to the first peak 
of d-wave. 
 
3.9 Data analysis of ERGs.  
Dark- and light-adapted a-, b-wave amplitudes and implicit times, light- and dark-adapted OPs, light-
adapted d-wave amplitudes and implicit times were measured and analyzed.  For each luminance-
response series, some overall parameters were derived using the appropriate curve-fitting methods. 
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Curve fitting for the stimulus-response series for the amplitudes of the dark-adapted a- and b-waves, 
the light-adapted b-wave and the PhNR were fitted using least-squares curve fitting based on the ERG 
measurements for each subject at each time point. For these measurements, parameters were obtained 
through curve fitting using the Naka-Rushton curve:   
(Vmax 𝑛𝑛∗ I𝑛𝑛) 
  
where V is the amplitude in response to a flash strength of I, Vmax is the maximum (saturated) 
amplitude, K is the sensitivity (flash strength at half Vmax) and the slope parameter (n) is constrained 
to 1 (Hamilton et al. 2007).   
R-studio set codes (Appendix E) was used for the least-squares fitting of Naka Rushton curves. In all 
cases of fitting R2 ≥ 0.88 or better was used. The set of codes was written by Vivian Choh, PhD and 
was modified by the candidate with permission. The Naka-Rushton equation of the dark-adapted a- 
and b-waves, as well as the light-adapted b-wave and PhNR, was constrained to a slope (n) of one (1) 
as suggested by Hamilton et al (2007) and as used in some chick stimulus-response fittings by 
Montiani-Ferreira et al. (2007). Following the suggested protocols of Severns and Johnson (1993) and 
Joshi et al. (2017), the Naka Rushton curve was used to fit all points of the ERG stimulus-response 
function, unless the last point of the function showed a decline following saturation or a sharp rise of 
the secondary rising function (Figure 7).  
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Figure 7: A representative fitting of the Naka-Rushton curve to a dark-adapted b-wave 
amplitude stimulus-response curve. The dark line indicates the part of the curve that was fitted, 
and grey point was excluded as part of the secondary rising phase (Severns & Johnston 1993).    
All light-adapted a-waves did not saturate at higher light intensities, and therefore were fitted with a 
power function:  
𝑉𝑉 = 𝑎𝑎 ∗𝑖𝑖𝑏𝑏  
where V is the light-adapted a-wave amplitude in response to the stimulus intensity, i, and a and b are 
parameters of the curve fit. In all cases, R2 ≥ 0.88 was considered a good fit. The light-adapted 
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amplitude used for the analysis was interpolated from the individually fitted power functions for a 
stimulus of 3 cd.s/m2.  
The extracted OPs amplitudes were quantified by calculating the root mean square (RMS) of signals 
within 5 to 55 ms post-flash. A similar method was used in the study of OPs by Wang et al. (2015) 
and Gur et al. (1987).  
The data were analyzed using GraphPad Prism version 9 software (GraphPad Prism Inc, San Diego, 
USA). The differences between eyes at baseline (day 0) for the chicken ERG data were analyzed a 
priori using paired t-tests.   
Two-way repeated-measures analysis of variance (ANOVA) was used to analyze the main effects of 
treatment (sham vs treatment) and age (maturation period of 3,5,7,14 and 21 days post-treatment), 
and the interaction (treatment x age) on NK-Rushton parameters (Vmax, K) of DA a- and b-waves 
and LA b-waves and PhNR), interpolated a-wave (for light-adapted a-wave) or long-flash ERG 
parameters as well as implicit times. In the event of missing data (as was the case in all the ONS 
studies), the two-way repeated ANOVA method was replaced by mixed-effects modelling. If the 
assumption of sphericity was violated, Greenhouse-Geisser corrections were used.   
Bonferroni test was used for post-hoc comparison. P ≤ 0.05 was considered statistically significant for 
all statistical tests in this study.  
Cohen’s d, d, was used for post-hoc power analysis to estimate the effect size of the main effect of 
treatment: 
𝑑𝑑 =





    
Where 𝜇𝜇 is the pooled mean and 𝜎𝜎 is the pooled standard deviation of the main effects in sham, 1, and 
treated, 2, eyes. As used by Ahmadieh et al. (2021) on ERG parameters, the Cohen’s d can be 
grouped into “negligible” (d<0.2), small (0.2<d<0.5), medium (0.5<d<0.8), large (d>0.8).  
 
3.9.1 Sample size calculations 
Due to the paucity of data on the effect of ONS on ERGs in birds, the sample size arrived at for this 
study was based on the rat model (L Alarcon-Martinez et al. 2009) and non-human primate model 
(Viswanathan et al., 1999) where at least 40% of STRs or PhNR were lost after RGC loss 
respectively. However, since there are notable differences in chicken and rodents’ and primates’ 
retinae, power calculations were based on a more conservative value for the expected difference of 
25%. Two-tailed analysis with an expected change of 25%, a standard deviation of 10%, alpha of 
0.05 and power goal of 0.80 gave the sample size of 4 (minimum), calculated using Statistica V8 
software (Statsoft Inc, Tulsa, OK). Hence, this study uses a minimum of n=4 birds for statistical 
analysis with 80% power to detect amplitude differences of 25%. 
The sample size calculation for the histology work is based on work done in our lab (Chong et al. 
2013)  with chicks which shows n=3 for statistical analysis with 80% power to detected differences. 
3.9.2 One-tailed or two-tailed analysis. 
For this thesis, two-tailed statistical analysis was employed throughout. Currently, several studies 
point to the fact that stress on RGC could lead to either reduction of ERG amplitudes (Bui and 
Fortune, 2004, Viswanathan et al., 1999) or its enhancement  (Choh et al., 2016, Tan et al., 2018). 
Since the effect of RGCs dysfunction could go either way, a two-tailed statistical analysis was 
performed throughout this study. 
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Because of the paucity of ERG data in chicks using coloured LED stimuli, preliminary experiments 
were carried out to inform the stimulus selection for the main studies.  
4.1 Pilot study 1: Effect of intra-orbital bleeding on subsequent light-adapted ERGs in 
chicks    
Purpose: It has been documented that the blood supply to the retina affects the ERGs of some species 
(Block and Schwarz, 1998). Little is known of the effect of the blood supply in chicken ERGs. 
Moreover, some surgeries in this study resulted in intra-orbital bleeding; therefore, a pilot study was 
undertaken to determine if chickens with intra-orbital bleeding should be excluded from the study. 
Methods: Light-adapted ERGs were recorded on day three post-ONS, using eyes of chicks with sham 
surgery performed at 1-day after hatch that bled during the procedure (n=5) or that did not bleed 
(n=5) during the procedure. The setup for the surgery and ERG is as described in section 3.3, and the 
setup for the ERGs was as described for light-adapted ERGs (section 3.8.2), except that stimuli were 
white flashes (3.0 cd.s/m2) on a white (30 cd/m2) background. 
Results and discussion: Three days after surgery, there were no differences in the amplitudes of the a-
waves (p = 0.88, t-test) or b-waves (p=0.980, t-test) or implicit times (a-wave: p = 0.73; b-wave: p = 
0.69) between the ERGs of sham-treated eyes in chicks that had intra-orbital bleeding and those that 
did not.  
Conclusion:  No further exclusion criteria relating to surgical bleeding were added to the study. Each 
eye of chicks with and without intra-orbital bleeding was included in all cohorts. 
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4.2 Pilot study 2: Comparison of broad spectrum and long wavelength stimuli for chick 
dark-adapted ERG luminance-response series 
Purpose: To determine the normal chick scotopic threshold response (STR) and dark-adapted ERG 
luminance-response series. Since the long-wavelength light activates mostly chicken retinal cones, a 
comparison of the ERGs from white light and red light could be used to indicate the differences of the 
cone ERG waveform from the rod ERG waveform. 
Method: The same procedure (section 3.8.1) for recording bilateral dark-adapted ERGs was used for 
3 normal (not treated) birds day 15 post-hatch. An additional red flash ERG luminance-response 
series using the long-wavelength LED flash stimulus (peak output of 650 nm) matched to the white 
stimuli for photopic time-integrated luminance up to the maximum of log -1.75 cd.s/m2 was 
conducted a day after the white flash dark-adapted ERGs series but within the same time (midnight to 
3 am). A description of the ERG waveforms of the left eye was reported. 
Results: For all chicks, there was no detectable dark-adapted ERG for very dim white or red flashes 
(-6 to -4 log cd.s/m2). For red and white flashes from -3.5 to -2.25 log cd.s/m2, ERGs tended to be 
small, below 4 µV. For both red and white light stimuli of -2.75 log cd.s/m2 and stronger, chicks 
show no negative going ERGs but a positive going ERGs. With increasing stimulus strength, the 
positive ERG waveform showed increasing amplitudes and shorter implicit times. The response from 
the white light showed larger amplitudes at lower thresholds as compared responses to red stimuli, 
which appeared smaller and double peaked. A typical dark-adapted luminance-response series for red 
and white flash stimuli is shown in Figure 8.  
Conclusion: Although the ERGs recorded between -3 and -2.25 log cd.s/m2 were small and most 
were below the 4 µV, it could be observed that such responses were real because they had low noise 
levels with averaging and the amplitude increased with stronger stimuli.  
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The positive waveforms of these near threshold ERGs to flash stimuli of -2.5 log cd.s/m2, -2.25 log 
cd.s/m2 and -2 log cd.s/m2 were considered the dark-adapted b-wave and were averaged for this 
analysis. White light stimuli were used for the dark-adapted ERGs in the main studies because white 
light produced larger amplitudes and single peaks, facilitating analysis. 
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Figure 8: A representative dark-adapted ERG luminance-response series to weak white- and 
red-flash stimuli.  
Dark-adapted ERGs to red (black line) and white (grey line) stimuli from a chick at day 15 (white 
flash) and day 16 (for red flash series). The dotted line shows decreasing implicit time of the DA 




    
4.3 Pilot study 3: Effects of spectral characteristics and duration on light-adapted ERGs 
in chicks  
Purpose: To inform the spectral characteristics and flash duration for stimulus selection for the light-
adapted ERG studies.   
Methods: Bilateral ERGs were recorded using the standard preparation and anesthesia (see section 
3.7) for four hatchlings with no other experimental intervention (normal) when they were 14- and 21-
days post-hatch. Following 10 minutes of light-adaptation, different stimulus combinations were used 
to determine suitable spectral characteristics for the flash stimulus and the 30 cd/m2, background 
illumination for brief flash ERGs. Additional studies were conducted to determine a suitable duration 
for long-flash stimuli using the same normal chicks. The parameters for the flashes used for the light-
adapted brief and long-flash ERG pilot studies are presented in Table 3.  
The mini-ganzfeld stimulators were supplied with three sets of narrow band-width LEDs, with peak 
outputs at a long wavelength (650 nm, ‘red’), a medium wavelength (510 nm. ‘green’) and a short 
wavelength (462 nm ‘blue’). All stimuli were calibrated using photopic spectral sensitivity. The three 
LED sources could be combined. Balanced output from the three sets of LED simulated broad 
spectrum (white) light. Long and medium wavelength outputs were combined for yellow stimuli. The 
strength of brief flashes was controlled by a combination of power to the LEDs and flash duration, as 




    
Table 3: Stimuli and background illumination for light-adapted ERGs.    




Brief-flash   1 cd.s/m2  White on White  
Red on Blue  
Green on Blue  
Yellow on Blue  
Spectral 
combination   
Long-flash 150 ms  250 cd/m2   White on White  
Red on Blue  
Green on Blue   
Stimulus duration  Long-flash  
5, 10, 30, 50, 100, 
150 and 200 ms  
250 cd/m2    Red on blue  
Stimulus luminance  Brief-flash   0.3, 1, 3, 5 & 8 
cd.s/m2  
Red on blue  
* All light adapting backgrounds were 30 cd/m2 for 10 minutes. 
Results: The light-adapted, 1 cd.s/m2, brief flash ERG waveforms using the different spectral 
combinations in Table 3 (top row) are shown in Figure 9. The series shows that ERGs to a red flash 
stimulus on blue rod-suppressing background elicit the largest amplitudes for a- and b-waves. This 
was also found for the oscillatory potentials and i-waves. 
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Figure 9: Representative ERGs from an untreated eye of a 14-day-old chick are shown for brief 
1.0 cd.s/m² flashes with 30 cd/m² backgrounds using different spectral combinations (Table 3).  
  
ERGs for the long-flash stimuli of 250 cd.s/m2, using different spectral combinations, are shown in 
Figure 10. The series shows that the ERGs in response to the red, long-flash stimulus on blue 
background provide the largest amplitudes and a well-defined offset d-wave. To determine the 
stimulus strength to use for the long-flash ERG studies, the 250 cd/m2 gave a larger d-wave compared 
with those for 25 and 700 cd/m2; the difference reached significance (p = 0.04) compared to the 25 





    
  
Figure 10: Representative ERGs for the long-flash stimuli of 150 ms at 250 cd/m2, using the 




    
  
Figure 11: The d-wave amplitude is shown for 4 normal chicks to different luminance levels for 
a long-red flash stimulus.   
The ERGs were recorded on 4 chicks who were 14-day post-hatch. * amplitudes (p = 0.04) were 
higher for stronger stimuli, (250 cd/m2 and 750 cd/m2) than those for the long-flash stimulus of 
25 cd/m2 stimulus.   
 
For flashes from 5 to 20 ms duration the onset and offset ERG waveforms overlapped and could not 
be independently distinguished (Figure 12). For red-on-blue long-flashes, the onset and offset ERGs 




    
 
  
Figure 12: A representative long-flash ERG series from a normal chick recorded 14 days post- 
for stimuli with different stimulus durations (5 - 200 ms) using 250 cd/m2 blue flash on a 30 cd/ 
m2 blue background.   
 
Conclusions: Red flash (1 cd.s/m2) on a blue (30 cd/m2) background was chosen as the stimulus 
combination to measure the PhNR in the main light-adapted ERG study. For the long-flash ERGs 
studies, the red on blue stimulus was chosen with the red flash luminance of 250 cd/m2. The duration 
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of 150 ms was chosen to match the ISCEV extended protocol, although only the very short durations 
(< 30 ms) caused overlap between the on- and off-responses.   
4.4 Summary of final method 
Following the pilot studies, the protocols for the main were fixed. These are summarized below along 
with a synopsis of the methods from Chapter 3. 
4.4.1 The effect of ONS on chicken flash ERGs and retinal histology 
Histology 
For the histology, six chickens with ONS treated (n=6) and contralateral sham (n=6) eyes were used. 
The total number of cells at GCL layers and INL layers were counted across the Z-stack images of the 
chicken central region of the retina.  
ONS and ERGs 
The optic nerve sectioning (ONS) and electroretinograms (ERG) procedures were performed as 
described in sections 3.2 to 3.5, 3.7 and 3.8. Separate ONS birds were used to collect the dark-adapted 
and light-adapted ERGs (ONS total: n=22). The ERGs done on the chickens were grouped into dark-
adapted (DA) ERGs (DA standard b-wave, dark-adapted a- and b-waves, n=6), light-adapted (LA) 
ERGs (a-, b-waves, PhNR, n=10), long-flash ERGs (a-, b-, and d-waves, n=8). From the pilot 2 study, 
data from 0.01 cd.s/m2 stimuli were analyzed as the DA standard (0.01) b-wave, and DA b-wave 
curve fitting used responses to 0.01 cd.s/m2 and stronger because responses from below 0.01 cd.s/m2 
stimuli were below noise level in some cases. The sample size of each group is as shown in Figure 13. 
The minimum sample size of 4 was calculated as described in section 3.9.1.  Each study was carried 
out on separate birds except for the light-adapted ERGs groups, for which two birds in the ONS group 
(Figure 13) were used for both brief and long-flash light-adapted ERGs. For the optic nerve-sectioned 
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(ONS) group of birds, ERGs were collected when the bird were one-day old, just prior to ONS 
surgery (refers to 0 post-treatment), and again at days 3, 5, 7, 14 and 21 post-treatment. 
 
 
Figure 13: A Venn diagram outlining the number and distribution of birds in the ONS 
experimental groups.  
4.4.2 The effect of TTX on chicken flash ERGs 
Similar to 4.5.1, the intravitreal injections of TTX and ERG procedures were performed as described 
in 3.2 to 3.5, 3.7 and 3.8. Separate TTX birds were used to collect the dark-adapted and light-adapted 
ERGs (total TTX: n=14). The ERGs done on the chickens were grouped into DA ERGs (n=5), LA 
ERGs (n=5), long-flash ERGs (n=6). From the pilot 2 study, only data from 0.01 cd.s/m2 stimuli was 
analyzed for DA standard (0.01) b-wave because the response from below 0.01 cd.s/m2 stimuli was 
below noise level. Each study was carried out on separate birds except for the light-adapted ERGs 
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ERGs. The sample size of each group is as shown in Figure 14. The minimum sample size of 4 was 
calculated as described in section 3.6.1. For the intravitreal injection of TTX groups of birds, ERGs 
were collected when the birds were one day old, prior to the first intravitreal injection of TTX (refers 
to 0 post-treatment), and again at days 3, 5, 7, 14 and 21 after the first injection (post-baseline). The 
injection was repeated before each ERGs as described in section 3.4.  
 
 Figure 14: A Venn diagram outlining the intravitreal injection of TTX experimental groups 
and the distribution of birds. 
4.4.3 Effect of ONS or TTX on long-flash light-adapted chicken ERGs 
For the long-flash ERGs studies, the red on blue stimulus was chosen with the red flash luminance of 
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the very short durations (< 30 ms) caused overlap between the on- and off-responses.  A total of 8 




    
Chapter 5 
Effect of Optic Nerve Section (ONS) on the chicken ERGs and retinal 
histology. 
5.1 Introduction 
The chapter covers the results of the experiments to determine the effect of disrupting retinal function 
using optic nerve-section surgery (ONS). The focus of this thesis is to find out whether ERG 
waveforms known to detect RGC deficits in humans can also detect RGC deficits in chickens. 
5.2 Effect of the ONS on chicken retinal histology 
To determine the effect the ONS on the chicken retinal GCL (ganglion cell layer) and INL (inner 
nuclear layer), the retina from 6 ONS chicks sacrificed at 21 days post-treatment were analyzed. 
Retinal tissues were stained with DAPI, and the retinal images were analyzed (see section 3.6 and 
3.6.1). Images of the retina of  the treated (ONS) and sham control eyes are shown in Figure 15, 
where these representative images show the depleted RGC cells from the ONS eye.  The cell count 
across an average length of 464 µm of the GCL layers (Figure 16) of the ONS treated eyes were 
fewer than those of the sham treated eyes (52.2 ± 18.9 vs 245.3 ± 34.9 cells/mm, respectively; p 
<0.0001, N=6, paired t-test).  
For the INL (Figure 17), the cell count for 6 pairs of eyes sampled in 100 µm wide boxes that span 
the depth of INL (average of three counts) were similar for the treated and sham ONS eyes (numbers, 
p=0.41, N=6, paired t-test). ONS selectively induced reduction of cells in the chicken GCL with a 
mean loss of 78.7% of the nuclei in the GCL. However, the cell counts in the INL were not different, 














Figure 15: Representative retinal sections labelled with DAPI (blue nuclear stain) of sham-ONS (A) 
chicken retina and ONS (B) chicken retina. 



























Figure 16: Total number of cells in the ganglion cell layer (GCL) across a 464 µm image of the 
optic nerve sectioned (ONS) and sham treated chicken eyes. 
Mean, error bars showing standard deviation and dots showing the average counts from individual 
eyes.  The **** denotes p-value of ≤ 0.0001 (n=6).  
The figure shows that there were fewer cells in the GC layer of the ONS eye than in the sham treated 
eyes of the same chicks sacrificed on day 21 post-ONS and sham treatments. 
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Figure 17: Total number of cells in the inner nuclear layer (INL) per mm of the optic nerve 
sectioned (ONS) and of sham operated chicken eyes with the mean, error bars showing standard 
deviation and dots shows the averaged counts from individual eyes. 
The ns denotes no statistical difference (n=6). The figure shows that there were similar number (p=41) 




    
5.3 Survival for the ONS chicks for ERGs. 
Three birds (1 for dark-adapted group and 2 light-adapted group) were lost on day 10 post-ONS. 
Therefore, complete dark-adapted (DA) ERG results are reported for 5 birds along with results up to 7 
days for the one additional bird. For light-adapted (LA) ERGs, complete results are reported for 8 
birds along with results up to 7 days for the two additional birds.  
5.4 Dark-adapted ERGs of ONS chicken eyes 
5.4.1 Effect of ONS on chicken dark-adapted b-wave amplitudes in response to 0.01 
cd.s/m2 (DA 0.01 b-wave).  
The DA b-wave ERG amplitudes in response to 0.01 cd.s/m2 stimuli (DA 0.01 b-wave) was similar 
(paired t-test, p = 0.21, N=6) between the pre-treated eyes at day 0 (baseline). The ONS and sham 
treated fellow eyes (treatment) were not different (main effect of treatment: p=0.59, Cohen’s d, 
d=0.36, N=6), suggesting that ONS does not affect the DA 0.01 b-wave ERG amplitudes. A main 
effect of age was detected (p=0.003). Bonferroni’s post-hoc showed increasing amplitudes between 
day 3 post-treatment to 7 (p=0.02) and decreasing amplitudes between days 14 to 21 post-treatment 
(p=0.04; Figure 18). There was no significant interaction of age and treated eyes on the DA 0.01 b-






    
 
















Figure 18: Mean dark-adapted Standard b-wave amplitudes ± SD of ONS-treated eyes and 
sham fellow eyes at 0, 3, 5, 7, 14- and 21-days post-treatment (n=6 chicks)  
Stimuli were 4ms DA flashes of 0.01 cd.s/m2. Note that on day 0 neither eye had undergone 




    
5.4.2 Dark-adapted oscillatory potentials of ONS chicken eyes 
OPs were clearly recorded from all chick eyes, as shown in Figure 19. The RMS amplitudes 
between 5 and 55 ms for the 3 cd.s/m2 white flash stimulus are shown in Table 4. The pre-
treatment eyes (day 0) were not different (p=0.34, N=6) in OP amplitude. There was no 
significant difference (p=0.51) between the sham and ONS eyes (Table 4), as demonstrated by the 
inconsistent trend of the lower RMS amplitudes for the ONS eyes on days 3, 7 and 21 but higher 
RMS amplitudes for days 5 and 21 post-treatments compared with the sham eyes (Table 4). There 
was no significant difference of the OP RMS amplitudes across the days post-treatment, age 
(p=0.51), nor the interaction of treatment and age (p=0.35).  
  
Figure 19: Representative DA oscillatory potentials of optic nerve-sectioned and sham eyes of 
the same chick. 
The chick was 14 days post-ONS. Stimuli were brief flashes of 3.0 cd.s/m2.   
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Treatment, Mean RMS amplitude ± SD, µV  
Sham  ONS  
0 (pre-treatment) 31.60 ± 16.68 31.21 ± 6.08 
3  37.21 ± 10.42 36.84 ± 6.16 
5  24.14 ± 3.55 28.38 ± 6.54 
7  33.95 ± 14.88 28.78 ± 12.54 
14  35.76 ± 9.88  32.10 ± 12.50 
21  31.19 ± 9.76  33.04 ± 9.80  
  
For the DA OPs, this study of 6 pairs of chicks’ eyes had the power (80%) to detect a difference in 




    
5.5 Dark-adapted a- and b-waves of ONS chicken eyes 
The DA saturated amplitudes (Vmax of the amplitudes fit with the NK equation) for the DA-ERG a-
waves are illustrated in Figure 20. The pre-treated eyes (day 0) ERG data showed no significant 
differences in DA a-wave Vmax (p=0.34, N=6) and IT (p=0.74, N=6). The ONS did not affect the 
Vmax or the interpolated IT at 3 cd.s/m2 of the DA a-waves (Vmax: p=0.38, d=0.32; IT: p=0.52, 
d=0.32) post-treatment (3 to 21 days). The a-wave amplitudes of both eyes generally grew (not 
significant) till day 14 and dipped (not significant) on day 5 and 21 post-treatment, while the IT of 
the eyes generally reduced across the period, but there was no main effect of age between 3- and 21-
days post-treatment (a-wave: p=0.051, d=0.48, IT: p=0.11) and no interaction (a-wave: p=0.11, IT: 
p=34) 
The Vmax of DA b-wave amplitudes and interpolated ITs showed no significant difference between 
the untreated eyes at day 0 (b-wave Vmax: p=0.49, IT: p=0.10) and no significant change of between 
the post-treated eyes (amplitude: p=0.98, d=0.03; IT: p=0.22, d=42). There was no significant 
difference in both eyes with age (p=0.12), as demonstrated by the inconsistent trend of the Vmax 
amplitudes of both eyes dipping on days 5, and 21 but increasing on days 3, 7 and 14 post-treatments 
(Figure 21). Similarly, the IT of the interpolated b-wave of both eyes did not change significantly 
across over the period of the experiment (IT: p=0.90). There were no interactions of age and 
treatment in either the Vmax or IT (b-wave: p=0.21, IT: p=0.27). 
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Figure 20: The time course of dark-adapted a-wave saturated amplitudes (Vmax), and implicit 
time interpolated at 3 cd.s/m2 without treatment at day 0 and at 3-, 5-, 7-, 14- and 21-days post-
treatment in treated chicks (n=6), for DA ERG luminance series from 0.0562to 31.6 cd.s/m2.  
The point is the mean and error bars standard deviation (SD). The figure shows no statistical 
significance in Vmax or IT for DA a-waves. 
 
 











































 Figure 21: The time course of dark-adapted b-wave saturated amplitudes (Vmax), and implicit 
time interpolated at 3 cd.s/m2 without treatment at day 0 and at 3-, 5-, 7-, 14- and 21-days post-
treatment in treated chicks (n=6), for luminance 0.0562 to 31.6 cd.s/m2. 
The point is the mean and error bars standard deviation (SD). The figure shows no statistical 




    
For the NK Rushton sensitivity parameter, K, the dark-adapted a-waves reached half of Vmax for 
stimuli below the strength of the standard flash (mean (from log values) K = 1.74 cd.s/m2). B-waves 
were more sensitive, with K values for half Vmax at an average of 0.360 cd.s/m2 (converted from the 
mean of log values). Sensitivity, K values, for DA a- and b-waves showed no differences between 
eyes on baseline day 0 (a-wave: p=0.45, b-wave p=0.13), showed no effect of the ONS on K for 
either a-waves (a-wave: p=0.17, d=0.60) or b-waves (p=0.25, d=0.35) between the treated and the 
sham eyes as illustrated in Table 5. In addition, sensitivity did not change significantly with age for 
a-wave: p=0.51 but changed for b-waves (p=0.02) between 3- and 21-days post-ONS. No interaction 
of treatment and age was detected for both a-wave (p=0.44) and b-wave (p=0.52). 
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Table 5: Naka-Rushton equation sensitivity, K (flash strength at half Vmax) of dark-adapted a- 
and b-waves of chickens in the ONS group.  
Post-ONS Time, Days 
N=6  
Mean DA a-wave sensitivity, K (cd.s/m2) ± SD, µV  
Sham ONS 
0 (pre-treatment) 2.05 ± 1.07  1.69 ± 0.37 
3  1.17 ± 0.21  1.26 ± 0.57  
5  1.57 ± 0.64 1.25 ± 0.64  
7  2.34 ± 1.38  1.52 ± 0.76  
14  2.39 ± 0.51  2.47 ± 0.78  
21  2.47 ± 0.75  1.64 ± 0.72  
Post-ONS Time, Days 
n=6 
Mean DA b-wave sensitivity, K (cd.s/m2) ± SD, µV * 
Sham ONS 
0 (pre-treatment) 0.49 ± 0.23  0.42 ± 0.12  
3  0.21 ± 0.10  0.32 ± 0.05  
5  0.41 ± 0.21  0.39 ± 0.09  
7  0.43 ± 0.16  0.42 ± 0.09  
14  0.31 ± 0.08  0.19 ± 0.08  
21  0.41 ± 0.09  0.49 ± 0.09  




    
5.6 Effect of ONS on chick light-adapted ERG  
Over the 21-days for all the light-adapted (LA) ERGs, the a- and b-waves were clearly recordable in 
all eyes for flashed from 0.3 to 5.6 cd.s/m2 (Table 2). Figure 22 shows representative Standard LA 3.0 
ERGs. For the LA standard ERGs, were no differences in the amplitudes between the treatments 
(p=0.30, d=0.49 and p=0.33, d=0.22 for a-and b-wave amplitudes, respectively), nor were there 
differences with maturation (p=0.16 and p=0.19, for a-and b-wave amplitudes, respectively) nor were 
there any significant differences in interactions (p=0.82 and p=0.60, for a-and b-wave amplitudes, 
respectively) 
 
Figure 22: Representative LA Standard ERGs from Sham and ONS eyes of a five-day post-
ONS chicken. 
ERGs stimulus was a 3.0 cd.s/m2  white flash on a 30 cd/m2 background. 
 
At pre-treatment day 0 (1-day post-hatch), the retinal function of the chickens' right and left eyes 
were similar for all parameters measured (p>0.05). The ONS did not affect the LA implicit times 



















    
wave interpolated ITs, respectively).  Figure 23 shows the LA ERG results for power function 
interpolation of a-waves at 3 cd.s/m2 and for Vmax for LA b-waves in ONS and sham treated eyes 
across the age range. The LA a-wave interpolated amplitude and b-wave Vmax of both eyes appears 
increased (not significant) with maturation except for a transient decrease (not significant) at day 7 
post-treatment, but these changes in the amplitude of both eyes were not significant over age (p=0.24 
and p=0.30, for a- and b-wave ITs, respectively). There were no interactions of the two (p=0.61 and 
p=0.91, for a- and b-wave ITs, respectively). The sensitivity NK Rushton equation parameter, K, 
(flash luminance resulting in half Vmax) of light-adapted b-waves (Table 6) were not statistically 
different between the treated and the sham eyes (ONS: p = 0.50, d=0.13), nor was there an effect of 




    



















































































Figure 23: The time course of light-adapted a-wave amplitude interpolated at 3.0 cd.s/m2, 
saturated b-wave amplitudes (Vmax), and implicit times for a- and b-waves at 3 cd.s/m2 without 
treatment at day 0 and at 3-, 5-, 7-, 14- and 21-days post-treatment in ONS treated chicks 
(n=10), for an ERG luminance series with stimuli ranging from 0.0562 to 5.6 cd.s/m2. 
The point is the mean and error bars standard deviation (SD). The figure shows no statistical 
significance in LA a-wave amplitude interpolated at 3.0 cd.s/m2  and a-wave IT and LA b-wave 




    
 
Prior to treatment, there was no difference in the Vmax of the PhNR (Figure 23), (p=0.90) nor in the 
PhNR IT (p=0.32) between sham treated and ONS eyes prior to treatment (day 0). There were no 
significant differences in Vmax or implicit time, IT, between sham and ONS treated eyes (Vmax: 
p=0.92, d=0.18; IT: p=0.13, d= 0.31). Figure 23 shows the saturated amplitudes, Vmax, of the PhNR 
measured to the b-wave and ITs to the PhNR trough. While Vmax of the ONS eyes increased till day 
5 post-ONS and decreased marginally from 7 to 21, the control sham eyes dropped by 15% at day 7 
and 21 post-treatment. However, these changes were not significant by age (Vmax: p=0.42, IT: 
p=0.10) and there were no interactions between age and treatment (Vmax: p=0.23, IT: p=0.71).  
No differences in PhNR sensitivity (Table 6), pre-treated eyes (p=0.09), in the post treated eyes 
(p=0.17), by age (p=0.44), nor was there an interaction between age and treatment (p=0.70) for 




    









































Figure 24: The time course of light-adapted PhNR saturated amplitudes (Vmax), and implicit 
time at interpolated at 3 cd.s/m2 without treatment at day 0 and at 3-, 5-, 7-, 14- and 21-days 
post-treatment in treated chicks (n=10), for luminance 0.0562 to 5.6 cd.s/m2. 
The point is the mean and error bars, standard deviation (SD). The figure shows no statistical 




    
Table 6: Sensitivity, K (luminance at half Vmax), of light-adapted b-wave and PhNR of ONS 
group chickens.  
Post-ONS Time, Days 
n=10  
LA b-wave sensitivity, K (cd.s/m2) ± SD  
Sham ONS 
0 (pre-treatment) 1.97 ± 0.05  1.92 ± 1.26 
3  1.87 ± 0.43  1.80 ± 0.99  
5  1.37 ± 0.92  1.50 ± 0.89  
7  1.37 ± 0.79 1.47 ± 0.98  
14  1.22 ± 0.56 2.38 ± 0.92  
21  0.92 ± 0.37  1.23 ± 0.82  
Post-ONS Time, Days 
n=10 
LA PhNR sensitivity, K (cd.s/m2) ± SD  
Sham ONS 
0 (-pre-treatment) 1.52 ± 0.13   1.64 ± 0.19  
3  1.24 ± 0.20  1.16 ± 0.17  
5  1.03 ± 0.12  1.06 ± 0.20  
7  1.00 ± 0.13  0.90 ± 0.18  
14  0.72 ± 0.19  1.90 ± 0.90  







    
5.7 Effect of ONS on chick long-flash ERG amplitudes and implicit time  
The long-flash (250 cd/m2) ERG onset waveforms were clearly recordable in all eyes at all ages. 
Neither amplitudes nor implicit times of the onset a-waves differed between the ONS and sham 
treated eyes, and there was no effect of age nor an interaction between age and treatment (pre-
treatment p=0.56, treatment; p=0.38, age: p=0.69 or interaction: p=0.67). Similarly, no differences in 
the onset b-wave amplitudes were found by pre-treatment (p=0.46), by treatment (p=0.48), by age 
(p=0.07), nor was there an interaction between treatment and age (p=0.93). Indicating that the ONS 
did not affect the photoreceptors and bipolar cells between the eyes and over the period of studies. 
The offset d-waves measured from the treatment at offset were clearly recordable in all eyes. D-wave 
amplitude (mean 64.29 µV ±14.35 µV) was approximately half of the amplitude of the onset b-waves 
for the same stimulus. Figure 25 shows there was steady rise of d-wave amplitude to day 7, which 
then plateaued. The ONS eye dropped below the treatment at day 7, increased in day 14 but 
marginally dropped at day 21. For the offset d-wave amplitude, there was an overall a main effect of 
smaller amplitudes in the ONS eyes compared with the sham eyes (p=0.008), but there were no 
differences in amplitude by age (p=0.67) or interaction between age and treatment (p=0.45). On 
Bonferroni's multiple comparisons post-hoc testing for differences at specific ages, the d-wave 
amplitude for the ONS treated eyes was decreased significantly (p=0.04) at day 7. No difference in d-
wave implicit times (mean ±SD) were found between eyes pre-treatment (p=0.34), by treatment 




    

























Figure 25: The time course of long-flash (250 cd/m2) offset d-wave amplitudes before ONS and 
3-, 5-, 7-, 14- and 21-days post-ONS (n=8). 
There is a main effect of the ONS treatment and the significant difference (p=0.04) of eye treatment 
on day 7 post-treatment is indicated (**).  
 
5.8 Summary 
In summary, the ONS study shows no effect of treatment on the DA standard b-wave amplitude, LA 
PhNR but showed treatment effect of the d-wave. Furthermore, this study also detected main effect of 
age (maturation) on DA standard b-wave amplitudes and Naka-Rushton equation sensitivity, K (half 
Vmax intensity) of the DA b-wave.  
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Chapter 6 
Effect of intravitreal injection of tetrodotoxin, TTX, on the chicken ERGs. 
6.1 Survival for the TTX chicks for ERGs. 
There was no loss of birds in the TTX experiment, and repeated measures ANOVA was used to 
analyze the ERG data from the post-treated chickens.  
6.2 Effect of intravitreal injection of TTX on chicken DA b-wave to 0.01 cd.s/m2 stimuli. 
The b-wave amplitudes of the sham and TTX treated eyes for luminance level at 0.01 cd.s/m2 (DA 
0.01 b-wave) at each of the time points, as illustrated in Figure 25. The sham b-waves amplitudes 
increased from day 5 post-treatment to day 14 and plateaued at 21 days. A similar trend was observed 
for the TTX treated eyes except for a dip (not significant) in the amplitude on day 5 and marginally 
at 14. At day 0 (baseline), there were no differences (p=0.21) in the DA standard b-wave amplitudes 
between the eyes (pre-treatment). The amplitude difference between TTX and sham injected, fellow 
eyes (treatment) was not significant (p=0.96, post-hoc power analysis, d=0.05, n=5). The DA 0.01 b-
wave amplitudes did increase significantly with age of both eyes (p=0.009). The interactions of 
treatment and age of both eyes were not significant (p=0.57). 
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Figure 26: Dark-adapted DA 0.01 b-wave amplitudes at 0, 3, 5, 7, 14 and 21-days post-
baseline is shown for five chicks with TTX treated eyes and sham fellow eyes. 
Stimuli were 4ms flashes 0.01 cd.s/m2. Note that on day 0 neither eye had undergone baseline. 
The point is the mean and error bars standard deviation (SD). The DA 0.01 b-wave amplitudes did 




    
6.3 The effect of TTX on chicken oscillatory potential 
The root mean square (RMS) of the OP amplitudes between 5 and 55 ms for the 3 cd.s/m2 flash 
stimulus are shown in (Table 7). At baseline day 0 (pre-treatment), there were no differences 
(p=0.77) in OP amplitudes between the eyes, and there were no differences (p=0.18, d=0.24, n=5) 
between the treated eyes and sham eyes (treatment) across the period, 3- to 21 days post-baseline. 
Table 7 shows the chicken DA OPs RMS increased from day 5 to day 7 before saturating to day 21, 
but the increases by age were not significant (p=0.06), and there were no interactions of treatment 
and age (p=0.90). 
Table 7: Table of RMS amplitude of dark-adapted OPs to 3.cd.s/m2 flash in the TTX groups of 
chickens. 
Days post-baseline  
N=5  
Treatment, RMS amplitude (µV)  
PBS (sham)  TTX  
0  2.28 ± 1.11  1.89 ± 0.84  
3  2.02 ± 1.43   2.05 ± 1.46  
5  1.56 ± 0.59  1.92 ± 0.93  
7  3.86 ± 2.62  4.11 ± 2.21  
14  2.94 ± 0.41  3.03 ± 0.39  
21  2.75 ± 0.43  3.08 ± 0.29  




    
6.4 Effect of intravitreal injection of TTX on chicken dark-adapted, DA, ERG 
The TTX DA-ERG a-wave saturated amplitude (Vmax) and interpolated implicit time (IT) at 3 
cd.s/m2 are illustrated in Figure 27. From Figure 27, at baseline (day 0), there were no differences in 
a-wave Vmax amplitudes and IT between the pre-treatment eyes (a-wave: p=0.86, IT=p=0.56, n=5). 
Additionally, no differences (a-waves: p=0.17, d=0.24; IT: p=0.52, d=0.31, n=5) in the post-baseline 
eyes across the treatment period. The a-wave amplitudes of both the sham and treated eyes appear to 
decrease marginally from day 0 to day 5 post-baseline but grew (observed) at day 7 before saturating 
at 14- and 21- days post-baseline but these changes over time were not significant (a-wave: p=0.27). 
The a-wave IT of both eyes generally appear to decrease (observed, not statistically significant, 
p=0.11) with age from post-baseline day 5 to 21. There were no interactions (Vmax: p=0.77, IT: 
p=0.46) between the effects of the treatment and age.  











































Figure 27: The time course of dark-adapted a-wave saturated amplitudes (Vmax) and IT 
without treatment at day 0 and at 3-, 5-, 7-, 14- and 21-days post-baseline in treated chicks (5 
TTX), for luminance 0.0562 to 31.6 cd.s/m2. 
The point is the mean and error bars standard deviation (SD). The figure shows no statistical 




    
The DA b-wave Vmax amplitude of untreated baseline eyes (p=0.03) differed between the eyes that 
was subsequently treated with TTX and those that became sham eyes, although the b-wave IT was 
same (p=0.52), but Vmax or implicit times (IT) of the b-waves did not change as a function of 
treatment (DA b-wave Vmax: p=0.69, d=0.06, IT: p=0.36, n=5). The pattern of b-wave ERGs 
(saturated amplitude and implicit time) changes with age followed a similar observed trend as the a-
wave amplitudes, except for decreased saturated amplitudes of the treated (TTX) eyes at day 5 and a 
dip (not significant) in the IT at day 3 post-baseline (Figure 28) but the observed changes with age 
were not significant (DA b-wave: p=0.28, IT: p=0.31) as well, there was no interaction of age and 
treatment (amplitude: p=0.50, IT: p=0.37).  
 









































Figure 28: The time course of dark-adapted b-wave saturated amplitudes (Vmax) and IT 
without treatment at day 0 and at 3-, 5-, 7-, 14- and 21-days post-baseline in treated chicks (5 
TTX), for luminance 0.0562 to 31.6 cd.s/m2. 
The point is the mean and error bars standard deviation (SD).  
 
The NK Rushton sensitivity parameter, K, of the dark-adapted a-waves and b-waves baseline ERG 
data shows no differences between the untreated eyes at day 0 (p>0.50), and no differences in the K 
 
78  
    
values for the treated and sham eyes (a-wave: p=0.59, d=0.11; b-wave: p=0.64, d=0.07, n=5). From 
the Table 8, the sensitivity, K, appears to decrease with age except for day 3- and 5- post-baseline for 
a- and b-waves of the two eyes, respectively, but the changes with age were not significant (a-wave: 
p=0.34; b-wave: p=0.16). The interactions of baseline and age (a-wave: p=0.94; b-wave: p=0.90) of 
both eyes were also not significant. 
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Table 8: Sensitivity (K) (flash strength at half Vmax) of dark-adapted a- and b-waves of 
chickens in the TTX group. 
Post-baseline Time, Days. 
n=5  
DA a-wave sensitivity, K (cd.s/m2)  
PBS (sham) TTX 
0 (Pre-treatment) 2.06 ± 0.93  1.76 ± 0.80  
3  1.93 ± 0.88  1.56 ± 0.49  
5  2.06 ± 0.84 1.95 ± 1.01  
7  1.37 ± 0.34  1.42 ± 0.50  
14  1.65 ± 0.72  1.47 ± 0.66  
21  1.56 ± 0.29  1.66 ± 0.64  
Post-baseline Time, Days. 
n=5 
DA b-wave sensitivity, K (cd.s/m2) 
PBS (sham) TTX 
0 (Pre-treatment)  0.48 ± 0.28  0.65 ± 0.23  
3  1.99 ± 3.42  1.17 ± 0.93  
5  0.79 ± 0.71  0.73 ± 0.42  
7  0.41 ± 0.39 0.31 ± 0.07  
14  0.32 ± 0.04 0.29 ± 0.09  
21  0.29 ± 0.10  0.40 ± 0.28  




    
6.5 Effect of TTX on chick light-adapted ERG amplitudes  
The pre-treatment (day 0) LA a-wave amplitude interpolated at 3 cd.s/m2 were asymmetric, with 
smaller a-waves in the eyes that were subsequently treated (p=0.003), but the ERGs from the TTX 
treated eyes were not significantly smaller than those of the sham eyes (p=0.06, d=0.58, n=5). The 
LA a-wave amplitude interpolated at 3 cd.s/m2 from both eyes decreased at day 5 post-baseline as 
shown in Figure 28. Both amplitudes increased (p=0.01) with age, and the interaction of treatment 
and age was not significant (p=0.09). The LA a-wave IT at 3 cd.s/m2 of between eyes were not 
different pre-treatment (p=0.70), or with treatment (p=0.06, d=0.48) but ITs in both eyes decreased 
(p<0.001) with age. The interaction of the LA a-wave IT with treatment and age was not significant 
(p=0.56). 










































Figure 29: The time course of for the maturation of the light adapted a-wave amplitude 
(interpolated at 3 cd.s/m2) and IT, before at day 0 (baseline, no treatment) and at 3-, 5-, 7-, 14- 
and 21- post-baseline in the TTX group. 
LA a-wave amplitude interpolated at 3 cd.s/m2 increased (p=0.01). The ITs in both eyes decreased 
(p<0.001) with age between 3 and 21 after treatment.  
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Similar to the DA b-wave amplitude, the LA b-wave saturated amplitude, Vmax, differed between 
the eyes that were subsequently treated with TTX and those that became sham eyes (p=0.003) at pre-
treatment day 0. The Vmax for the treatment sessions was not significantly different (p=0.86, d=0.09, 
n=5) between the TTX treated eye and the fellow eye but was different with age (p=0.003). The 
Vmax of both eyes appears to decrease at day 5, increase day 7 and decrease marginally by day 21 
post-baseline (Figure 29), but these differences are not significant. There was no interaction of 
treatment and age (p=0.72). The LA b-wave IT at 3 cd.s/m2 shows no significant differences between 
pre-treated eyes (p=0.77), between treated and sham eyes (p=0.26, d=0.17, n=5) but generally 
decreased (p=0.01) over the period of the experiment. There was no interaction (p=0.17) of treatment 
and age.  








































Figure 30: The time course of for the maturation of the light adapted Vmax b-wave amplitude 
and IT, before at day 0 (baseline, no treatment) and at 3-, 5-, 7-, 14- and 21- post-baseline in the 
TTX group. 
The point is the mean and error bars standard deviation (SD).  






    
For the sensitivity parameter K, (flash luminance resulting in half Vmax) of the light-adapted b-
waves, there were no differences (Table 9) between pretreated eyes (p=0.09), the treated and the 
sham eyes (p=0.051, d=0.61, n=5), nor did K change as a function of age (p=0.55).  There was no 
significant interaction of treatment and age (p=0.10). 




    
Post-TTX Time, Days 
n=5  
LA b-wave sensitivity, K (cd.s/m2) ± SD  
Sham TTX 
0 (pre-treatment) 1.49 ± 0.81  1.44 ± 1.19 
3  1.41 ± 0.70  1.39 ± 0.92  
5  1.24 ± 0.14  1.93 ± 0.77  
7  1.21 ± 0.33 1.61 ± 0.51  
14  1.45 ± 0.50 1.56 ± 0.27  
21  1.01 ± 0.29  1.31 ± 0.37  
Post-TTX Time, Days 
n=5 
PhNR sensitivity, K (cd.s/m2) ± SD 
Sham TTX 
0 (pre-treatment) 1.55 ± 0.19   1.61 ± 1.89  
3  1.29 ± 0.43  1.29 ± 0.77  
5  1.62 ± 0.60  2.64 ± 1.51  
7  2.65 ± 0.70  2.06 ± 1.08  
14  1.95 ± 0.66  2.13 ± 0.74  
21  1.15 ± 0.37  1.26 ± 0.38  
 
The day 0 baseline PhNR Vmax was different between the pretreated eyes (p=0.02) with the eye 
subsequently treated with TTX being smaller during the baseline sessions, but there was no 
difference in the PhNR Vmax values between the TTX eyes and the sham eyes (p=0.11, d=0.36, 
n=5). PhNR Vmax values did not change over time (p=0.06) despite a dip in the values between day 
3 and 5 and an apparent increase between day 5 and 7 (Figure 30). There was interaction of treatment 
and age (p=0.02) 
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The day 0 treatment IT was not different between the pretreated eyes (p=0.25), and there was no 
difference in the IT values between the eyes during the treatment sessions (p=0.09, d=0.36, n=5). The 
IT from both eyes generally decreased over time, but change was not significant (p=0.19), and the 
interactions were also not significant (p=0.15), as shown in  Figure 30.  
No differences in PhNR sensitivity, K, of between the eyes with pre-treatment (p=0.08), during the 
treatment sessions (p=0.17), with age (p=0.17), nor was there an interaction between treatment and 
age (p=0.18).  







































Figure 31: The time course of light-adapted PhNR saturated amplitudes (Vmax), and implicit 
time at interpolated at 3 cd.s/m2 without treatment at day 0 and at 3-, 5-, 7-, 14- and 21-days 
post-baseline (TTX) in treated chicks (n=5), for luminance 0.0562 to 5.6 cd.s/m2. 
The point is the mean and error bars standard deviation (SD).  
LA Vmax of PhNR increased (p=0.02) with age.  
 
 
6.6 Effect of TTX on chick long-flash ERG amplitudes and implicit time 
 TTX group waveforms did not differ significantly between pre-treated eyes at day 0 (p>0.05). There 
were no differences between the intravitreally TTX injected eyes and the sham injected control eyes 
in onset a-wave and b-wave (Table 10) amplitude (a-wave: p=0.40, b-wave: p=0.38, n=6) nor by age 
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(a-wave: p=0.13, b-wave: p=0.09) nor by interaction of age and treatment (a-wave: p=0.45, b-wave: 
p=0.51). Similarly, there were no differences in the implicit times between the treatment eyes for the 
onset a- and b-waves (p = 0.71; p= 0.54 for a- and b-waves, respectively, n=6), and no differences by 
age (a-wave: p=0.37, b-wave: p=0.20). The interactions for both long-flash a- and b-waves ITs were 
also not significant (p=0.83; p=0.61 for a- and b-waves, respectively). 
Table 10: Amplitudes of the long-flash onset ERG of TTX treated eyes and sham injected eyes. 
Treatment, n=6 Time post-baseline (days) 
Long-flash b-wave 
Amplitude ± SD (µV) 
Long-flash a-wave 
Amplitude ± SD (µV) 
Pre-treated eye 0 130.10 ± 9.16 39.3± 4.34 
Vehicle and TTX 
(treated) 
3 149.10 ± 9.56 48.90 ± 3.92 
 14 122.03 ± 24.16  50.70 ± 7.30 
 21 152.75 ± 27.83 48.47 ± 7.83 
Pre-treated eye 0 132.13 ± 10.35 40.54 ±5.89 
Vehicle (sham) 3 155.28 ± 13.62 53.44 ± 4.54 
 
14 132.67 ± 16.46 57.14 ± 4.20 
 





    
At pre-treatment, the d-waves were not different between the eyes (p=0.10). For the light-adapted 
long-flash offset d-wave, although there were no differences in the implicit time (p=0.10), there was a 
statistically significant difference (p=0.03, n=6) with the amplitude (Figure 33). The sham eyes’ d-
waves amplitudes were bigger than those of the treated eyes (Figure 32).  There were no differences 
in both eyes by age (d-wave amplitude: p=0.08, IT: p=0.20) nor interaction of age and treatment (d-
wave amplitude: p=0.12, IT: p=0.32) 
 
Figure 32: Representative of long-flash ERGs from the sham and TTX eyes of a 14-day post-









    
  
Figure 33: The time course of long-flash (250 cd/m2) offset d-wave amplitudes before TTX 
treatment and 3-, 14- and 21-days after baseline with TTX treatment each time (N=6). 
The sham eyes’ d-waves amplitudes were bigger than those of the treated eyes   
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This project ultimately seeks to determine the contribution of chicken RGCs to flash ERGs using 
PhNR, STR and photopic long-flash ERGs protocols with optic nerve section (ONS) and tetrodotoxin 
(TTX) which destroy or block RGC function, respectively.  
7.2 Optic nerve dysfunction 
This study shows that ONS- or TTX-induced optic nerve dysfunction results in delinking of the eye to 
the brain. This was demonstrated by the lack of pupillary constriction on direct pupillary tests on all 
the chickens used in this study. It has been reported by several authors that pupillary reaction test is a 
reliable method of testing the efficacy of the ONS/TTX (McBrien et al., 1995, Wong-Riley et al., 
1989b). Furthermore, the optokinetic method was employed in this study to further demonstrate the 
loss of retinal ganglion cells functions. The observed absence of the optokinetic response in the 
treated eyes further confirms the success of the RGC dysfunction methods employed in this study, 
and this work is consistent with study by Ostrin et al. (2016). 
ONS Histology 
The histology experiment shows selective reduction of retinal ganglion cells in the treated eye. 
Chong et al. (2013) also demonstrated that ONS is associated with loss of chicken RGCs. However, 
this study further demonstrated that the cells INL were not affected in ONS treated chicken eyes. 
Since the INL has both amacrine, on- and off-bipolar cells, it is likely that these cells were not 
affected by ONS in chicken. 
7.3  Dark-adapted ERGs and the STR  
The absence of a negative-going waveform in the scotopic threshold responses (STRs) in very dim 
flashes in chicks was reported in this study. Given that STRs are elicited from the rod pathway, it is 
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not surprising that chickens lack STRs. Unlike humans who have 1:20 rod:cone ratio (Jonas et al. 
1992), chicks have 2:3 ratio (Morris 1970, Wisely et al. 2017) as well as a circadian suppression of 
rod function during the daytime (Schaeffel et al. 1991). For very dim flashes, the chicken ERG, was 
relatively small as compared with human ERGs. It was suggested by Montiani-Ferreira et al. (2007) 
that perhaps the relatively fewer rods may account for the lower amplitude of the entire ERG 
waveform generated in across the scotopic range.   
The observed ERGs are like those described by Montiani-Ferreira et al (2007), who reported similar 
positive-going waves from dark-adapted ERGs from -2.4 log to -2 log cd/m2. Although a previous 
study by Schaeffel et al. (1991) shows that, in the dark-adapted state at the appropriate time in the 
circadian cycle, the rod pathway dominates the chickens' vision, no dark-adapted ERGs were 
detected from stimuli of -4.32 log cd.s/m2. In fact, the dark-adapted ERGs in the present study 
supports the work of Shi and Stell (2013), who found chickens threshold luminance is about – 4 log 
cd.s/m2 in 5- to 13-days old chicks. The slight difference in the threshold of -0.32 log cd.s/m2 found 
in the same age range as in the present study might be explained by the strain of chick used by the 
different studies. Shi and Stell (2013) used bovan chickens, a chicken strain reported to have higher 
night sensitivities, and Shi and Stell (2013) speculated that this strain might have higher rod:cone 
ratio than the domestic chick (used in this present study).   
Some mammals, such as guinea pigs that have a non-vascularized inner retina (Cringle et al. 1996), 
and also lack STR waveforms in ERGs elicited through the stimulus range that is sub-threshold for 
ERG b-waves (Lei 2003). Although the paucity of data on chick ERGs to subthreshold luminance 
levels makes it difficult to compare this result with other studies, it could be suggested that domestic 
chicks do not have negative STR waveforms and, therefore, the observed positive-going waveforms 
to dim stimuli is associated with b-waves (Figure 35). Furthermore, it can be observed from Figure 8 
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that the positive-going wave peak for dim stimuli has similar implicit times to those of b-waves, 
suggesting that the waves reflect rod bipolar activity and are not positive STRs.   
The absence of the negative STR waveform in all chicks gives rise to questions about the protocol 
and recording techniques, particularly as the STR is eliminated by incomplete dark adaptation or 
small amounts of light exposure. We, therefore, reproduced our chick STR protocol using a human 
participant for comparison (Appendix A); given the same protocol/stimulus parameters, STRs with 
both a negative and positive waveform are recordable in humans. The human negative STR was 
apparent for stimuli between -5.25 and -4.25 log cd.s/m2 (Figure 35). The use of similar instruments, 
recording parameters and light stimulus levels elicited STRs in the human subject but not in the 




    
Log cd.s/m2 Chicken (A)                  Log cd.s/m2     Human (B)    
  
Figure 34: A chicken (A) and human (B) representative dark-adapted ERG response to very 
dim white flash stimuli. 




    
7.4  Spectral characteristics and light-adapted long-flash ERGs  
From pilot study 3, red on blue long-flash ERGs had larger amplitudes than the other combinations 
of wavelengths used. This is different as compared to human long-flash where ERGs with red light 
on a blue background elicited the smallest long-flash ERGs (Sustar et al. 2006); Although the relative 
threshold sensitivity of the chick retina for medium and long-wavelength light is similar to that of 
humans, chicks have cone types with red/orange oil droplets (Bowmaker & Knowles, 1977; Kram et 
al. 2010). It is, therefore, possible that for suprathreshold stimuli, more photoreceptors in the chick 
respond to the red flash, resulting in a larger a-waves, and therefore also generating a larger b-wave. 
More importantly, the chick red on blue long-flash ERG showed a more distinct off response d-wave 
compared with those for the white-on-white stimulation. The d-waves of the chick to light-adapted 
long-flash ERGs show double peaks as in humans (Sustar et al. 2009, Horn et al. 2011, Morny et al. 
2019) and in non-human primates (Sieving et al. 1994, Ueno et al. 2006). Although limited studies 
have been done to conclusively determine which peaks of the d-wave reflect off bipolar cells in 
chicks, it is likely that the first peak reflects off-bipolar cell function as it does in the human. This 
assumption is based only on the fact that the chick and human long-flash ERGs have similar 
waveforms. Further investigation into the double peak of chick ERGs is indicated.  
7.5  Chicken photopic negative response (PhNR)  
As for the STRs, the light-adapted short-flash ERGs did not show remarkable PhNR waveforms 
regardless of the spectral characteristics of the stimulus. For brief flashes (pilot study 2), red on blue 
elicited ERGs with a clearer PhNR as well as prominent i-wave, as compared to the white-on-white 
ERGs. As above, the protocol was tested on a human participant to verify that that the PhNR could 
be recorded using these stimuli. A typical light-adapted luminance-response function from a 2-week-
old chick is compared with that of the adult human participant is shown in Figure 35. The 
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rudimentary PhNR in the chick is consistent with ERGs shown by Montiani-Ferreira et al. (2007) and 
by Ostrin et al. (2016). Nonetheless, this result is in contrast to the large negative PhNR from 
primates (Viswanathan et al. 1999, Frishman et al. 2018). It has been shown by Raz-Prag et al. 
(2010) that these negative going waves come from potassium rectifying channels in the glial cells in 
the ganglion cell layer that are activated upon retinal ganglion cells function. Perhaps the 
unremarkable PhNR in chicks is linked to the lack of intra-retinal astrocytes (Fischer et al. 2010). 
Furthermore, the K+ channels of glial cells (mostly Müller and intra-retinal astrocytes) draw into the 
cells the excess K+ in the extracellular space upon excitation of the RGC cells, Raz-Prag et al. (2010) 
suggesting that K+ ions are released in response to RGCs function. Since the chicks lack intra-retinal 
astrocytes, and therefore the associated rectifying channels, their PhNR amplitude is expectedly, 
small.    
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Figure 35: A representative ERG luminance series of a 14-day old light-adapted chicken (left) 
and human (right) light-adapted ERGs to a luminance series of 4ms red flashes on a blue 30 
cd.s/m2 background.     
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7.6 Effect of optic nerve-section (ONS) and intravitreal of tetrodotoxin (TTX) on the 
dark-adapted ERGs.   
The present study shows that ONS at one day post-hatch does not affect the rod bipolar of chick ERG 
throughout the 21 days after treatment (1 day post-hatch). A possible explanation relates to the 
absence of AII amacrine cells in the chicken retina (Quesada et al. 1988, Shi and Stell 2013). AII 
amacrine cells mediate dark-adapted vision in rod-dominant mammals as they connect rod bipolar 
cells to ganglion cells.  
Because in some species, RGC damage models affect b-waves and oscillatory potentials of dark-
adapted flash ERGs, analysis of the dark-adapted chick ERGs was carried out to determine if ONS or 
TTX affects flash dark-adapted chick ERGs.  Not surprisingly, none of the waveforms of the dark-
adapted ERGs was affected by the RGC attenuation. The limited report of the effect of the ONS or 
TTX on chick dark-adapted ERGs makes it difficult to compare this result with others. In this study, 
the dark-adapted chicks' a- and b-waves were not affected by RGC deficits.  Other studies have 
suggested that some vertebrate bipolar cells have TTX sensitive channels (Saszik and DeVries 2012) 
so that b-waves may be affected by TTX if the chick bipolar cells had such properties. However, in 
the present study, the reduction of the b-wave in the TTX group did not reach significance (p = 
0.311).    
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In some species such as rats and mice, it has been documented that attenuation of RGCs results in 
loss of dark-adapted OP amplitudes (Raviola and Gilula 1973). However, in this report of chicken 
ERGs, the amplitude of dark-adapted OPs was not affected by RGC deficits caused by either ONS or 
TTX. This study also differs from studies in humans (Raviola and Gilula 1973), where RGC deficit 
conditions resulted in the loss of OP amplitude. Although TTX blocks the chicken spiking amacrine 
cells (Wildsoet and Wallman 1995), TTX did not reduce the amplitudes of the dark-adapted OPs. 
The results suggest that amacrine cells may contribute to OP generation in humans but not in chicks, 
perhaps accounting, at least in part, for the interspecies differences.   
7.7 Effect of ONS and TTX on chick light-adapted ERG luminance-response series  
The PhNR was not significantly reduced in the treated eyes of either the ONS or TTX studies. 
However, the sham eyes PhNR amplitudes in the ONS study showed a trend towards being larger (p 
= 0.09). Similarly, in the TTX study, the PhNR tended to be larger in the sham (PBS injected) eyes 
but not significantly. The present results contrast with similar work done by Viswanathan et al. 
(1999) in primates, showing a substantial diminution of the PhNR amplitude with TTX injection. It 
could be suggested that since the PhNR was not reduced significantly in the treated chick, perhaps 
spiking RGCs do not contribute substantially to chick PhNR waveforms. This author did not find 
published data on chick PhNR; hence comparison within species is not possible.   
The ONS surgery and the subsequent loss of RGCs did not affect the a- and b-wave of the chick 
light-adapted ERGs. Similarly, no differences in the light-adapted a- or b-waves was found for eyes 
injected with TTX. These data match previous work done in our lab (Choh et al. 2004, Chong et al. 
2013) that shows that ONS selectively affects RGCs, hence no effect was demonstrated in the ERG 
waveforms generated by more distal cells. This work is also consistent with similar work done by 
Ostrin et al. (2016). The present study includes additional ERG protocols to probe cone function as 
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compared with Ostrin et al. (2016), such as the use of red on blue stimuli and a light-adapted 
luminance series as against white on white to one 3 cd.s/m2 short flash. Both studies showed that the 
b-wave amplitude reduction was not significant for any stimulus protocol. B-waves primarily 
originate from the bipolar cells and thus are not expected to be affected by ONS or TTX. There is 
limited literature pointing to the loss of bipolar cells in any species after ONS. However, we cannot 
discard the fact that some components of the b-wave might be affected. It has been noted by Sieving 
et al. (1994) that short flash b-wave amplitude reflects the function or contributions of both on- and 
off bipolar cells. Also, RGCs might contribute to the pull factor of the push and pull model of b-wave 
as postulated by Sieving et al. (1994). However, because the push factor (on-bipolar cell activated by 
the brief-flash stimuli) has more input and hence any reduction associated with RGC input to the pull 
factor (off bipolar cells) was not detectable.  
For the TTX experiment, DA b-wave, LA a-wave, LA b-wave,  and LA-PhNR amplitudes had 
significant inter-ocular differences (ID) in pre-treatment eyes. However, the results post-baseline is 
still valid due to the robust method used in the analysis. Firstly, the method of analysis repeated-
measures ANOVA was performed as suggested by Armstrong (2013) and as used in chicken ERG by 
Ostrin et al. (2016) on only the post-baseline data, and any significant differences in the treated and 
control eyes will have been captured. Secondly, although interocular differences were observed in the 
pre-treatment, it is worth noting that, in post-baseline, these differences became narrower, suggesting 
that the lack of significant differences in post-baseline could not be attributed to the pre-treatment ID. 
Thirdly, to account for the pre-existing difference between the eyes prior to treatment, the inter-ocular 
differences (calculated as treated eyes minus fellow eye changes, were compared as a function time) 
in LA ERG parameters at the various ages were analyzed (repeated measures ANOVA) (not 
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reported), where any significant changes from day 0 represent additional differences than the pre-
existing day 0 inter-ocular difference, but the result was not different from the reported results. 
7.8 Effect of TTX and ONS on chick light-adapted long-flash ERGs  
The investigation into which component of the short flash b-wave reflects chick RGC function 
resulted in a study of the effect of ONS on the on b-wave and off d-wave of the chick long-flash 
ERGs. Here, the results suggested that both TTX and ONS affect the retinal off-pathway. This result 
is consistent with work done by Petersen-Jones et al. (2010), which found that another RGC 
pharmacological blocking agent, NMDA, reduces the d-wave of chicks. The drug employed by 
Petersen-Jones et al. (2010) targets non-spiking RGCs, TTX targets spiking cells and ONS blocks 
both spiking and non-spiking RGC. Since all of these treatments reduce d-wave amplitudes, it could 
be postulated that both spiking and non-spiking RGCs contribute to chickens’ d-waves. Moreover, 
Awatramani et al. (2001) also noted this generalized trend and stated that in blocking the inner retinal 
functions, d-waves tend to be affected more than the on b-waves. Given that d-wave amplitude and 
implicit time seems to be preserved in RGC destructive conditions such as glaucoma (Horn et al. 
2011) and autosomal dominant optic atrophy (Morny et al. 2015), it could be suggested that an 
anatomical reason might account for the difference.  Chicks have an enhanced centrifugal vision 
system (CVS), efferent fibres from the brain to the retina, while such efferent fibres are rare in the 
primate retina (Gastinger et al. 2006). Most of the CVS fibres terminate close to off-bipolar cells and 
excite RGC cells (Lindstrom et al. 2010). It could be suggested that dysfunction of the CVS fibres by 
ONS or by blockage of RGCs with TTX in the treated eye could lead to decreased activity of the off-
bipolar cells and hence the reduced d-wave.    
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Both ONS and TTX studies show growth in the ERG waveform over time. This is consistent with 
studies done by Ookawa, T. (1971), which shows that the chicken ERGs grow over time. Ostrin et la. 
(2016), also demonstrated this maturation in ONS and sham-treated eyes.  
7.9 Summary and limitations 
This thesis explored the use of chicken ERGs to detect RGC functions. The ERGs protocols 
employed in this study were known to detect RGC functions in human subjects. However, this study 
suggests that chicken does not have a sub-threshold response, which implies that STRs do not reflect 
RGC functions in chicks. Moreover, another negative going ERG waveform, which is known to 
reflect RGCs function, the photopic negative response (PhNR), is small in growing white leghorn 
chickens (compared to humans). Finally, this thesis showed that offset d-wave possibly reflects RGCs 
functions.  
Furthermore, the pre-treatment day 0 (baseline) data shows bigger ERG values for the TTX group 
than the ERGs from the birds in the ONS group.  This may be due to different batches of chickens 
used for each study. We noticed the ERG amplitudes from the batch of chicken for the TTX group 
were bigger than for the batch for the ONS group, although the experiment was carried out in the 
same experimental conditions. For instance, the mean of the DA a-wave amplitude from the TTX 
group of birds was 15 µV, bigger than the ONS group at day 0. These differences in the treatment 
ERG data and the generally increased amplitude of ERG data from the TTX group make it difficult to 
compare the ERGs from the two groups. Also, both study groups were not carried out concurrently. It 




    
Moreover, the main effects of treated eye of flash ERG parameters measured in the thesis showed no 
significant difference. However, since the effect size analysis with Cohen’s d, shows none of these 
main effects of treatment had d> 60, it could be suggested the effect sizes were also not large enough. 
It is suggested that future studies, especially PhNR in chicks, should consider the low observed power 
analysis from this thesis and factor it into the sample size calculations. 
Although this study clearly demonstrated that the inner nuclear layer cells were not affected by the 
ONS, the d-wave from the chick retina was affected, suggesting future investigations into the effect 
of ONS or TTX on off-bipolar cells should be investigated in the future using immunohistology. 
Additionally, ERGs for the treated eyes and the control eyes were tested simultaneously in each bird 
to avoid testing effects, such as anesthesia (Choh et al., 2017) on ERG variability from sequential 
testing in this thesis. Although this type of design is the most used in ERG studies in chickens, it is 
possible that the ERGs could cross to the contralateral eye through volume conduction (ERG 
crosstalk) because chickens have small heads and have eyes close together. However, the possibility 
of this ERG cross talk affecting the results was minimized in this study since ERGs crosstalk from 
each eye could cancel out. In the future, chicken ERG interocular differences should be explored. The 
sham controls instead of naïve controls were used in this thesis because sham controls had the 
advantage of cancelling out the effect of the surgery/injection in both chicken eyes.  
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CC BY NC ND: The CC BY-NC-ND license allows users to copy and distribute 
the Article, provided this is not done for commercial purposes and further does not 
permit distribution of the Article if it is changed or edited in any way, and 
provided the user gives appropriate credit (with a link to the formal publication 
through the relevant DOI), provides a link to the license, and that the licensor is 
not represented as endorsing the use made of the work. The full details of the 
license are available at http://creativecommons.org/licenses/by-nc-nd/4.0. Any 
commercial reuse of Open Access articles published with a CC BY NC SA or CC 
BY NC ND license requires permission from Elsevier and will be subject to a fee.  
Commercial reuse includes:  
• Associating advertising with the full text of the Article  
• Charging fees for document delivery or access  
• Article aggregation  
• Systematic distribution via e-mail lists or share buttons  
Posting or linking by commercial companies for use by customers of those 
companies.  
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BOUND BY THE TERMS OF THIS LICENSE. TO THE EXTENT THIS LICENSE MAY  
BE CONSIDERED TO BE A CONTRACT, THE LICENSOR GRANTS YOU THE  
RIGHTS CONTAINED HERE IN CONSIDERATION OF YOUR ACCEPTANCE OF SUCH 
TERMS AND CONDITIONS.  
1. Definitions  
a. "Adaptation" means a work based upon the Work, or upon the Work and other  
pre-existing works, such as a translation, adaptation, derivative work, arrangement of music or other 
alterations of a literary or artistic work, or phonogram or performance and includes cinematographic 
adaptations or any other form in which the Work may be recast, transformed, or adapted including in 
any form recognizably derived from the original, except that a work that constitutes a Collection will 
not be considered an Adaptation for the purpose of this License. For the avoidance of doubt, where 
the Work is a musical work, performance or phonogram, the synchronization of the Work in 
timedrelation with a moving image ("synching") will be considered an Adaptation for the purpose of 
this License.  
b. "Collection" means a collection of literary or artistic works, such as  
encyclopedias and anthologies, or performances, phonograms or broadcasts, or other works or subject 
matter other than works listed in Section 1(f) below, which, by reason of the selection and 
arrangement of their contents, constitute intellectual creations, in which the Work is included in its 
entirety in unmodified form along with one or more other contributions, each constituting separate 
and independent works in themselves, which together are assembled into a collective whole. A work 
that constitutes a  
Collection will not be considered an Adaptation (as defined above) for the purposes of this License.  
c. "Distribute" means to make available to the public the original and copies of the Work or 
Adaptation, as appropriate, through sale or other transfer of ownership.  
d. "Licensor" means the individual, individuals, entity or entities that offer(s) the Work under 
the terms of this License.  
e. "Original Author" means, in the case of a literary or artistic work, the individual, 
individuals, entity or entities who created the Work or if no individual or entity can be identified, the 
publisher; and in addition (i) in the case of a performance the actors, singers, musicians, dancers, and 
other persons who act, sing, deliver, declaim, play in, interpret or otherwise perform literary or artistic 
works or expressions of folklore; (ii) in the case of a phonogram the producer being the person or 
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legal entity who first fixes the sounds of a performance or other sounds; and, (iii) in the case of 
broadcasts, the organization that transmits the broadcast.  
f. "Work" means the literary and/or artistic work offered under the terms of this License 
including without limitation any production in the literary, scientific and artistic domain, whatever 
may be the mode or form of its expression including digital form, such as a book, pamphlet and other 
writing; a lecture, address, sermon or other work of  
the same nature; a dramatic or dramatico-musical work; a choreographic work or entertainment in 
dumb show; a musical composition with or without words; a cinematographic work to which are 
assimilated works expressed by a process analogous to cinematography; a work of drawing, painting, 
architecture, sculpture, engraving or lithography; a photographic work to which are assimilated works 
expressed by a process analogous to photography; a work of applied art; an illustration, map, plan, 
sketch or three-dimensional work relative to geography, topography, architecture or science; a 
performance; a broadcast; a phonogram; a compilation of data to the extent it is protected as a 
copyrightable work; or a work performed by a variety or circus performer to the extent it is not 
otherwise considered a literary or artistic work.  
g. "You" means an individual or entity exercising rights under this License who has not 
previously violated the terms of this License with respect to the Work, or who has received express 
permission from the Licensor to exercise rights under this License despite a previous violation.  
h. "Publicly Perform" means to perform public recitations of the Work and to communicate to 
the public those public recitations, by any means or process, including by wire or wireless means or 
public digital performances; to make available to the public Works in such a way that members of the 
public may access these Works from a place and at a place individually chosen by them; to perform 
the Work to the public by any means or process and the communication to the public of the 
performances of the Work, including by public digital performance; to broadcast and rebroadcast the 
Work by any means including signs, sounds or images.  
i. "Reproduce" means to make copies of the Work by any means including without limitation 
by sound or visual recordings and the right of fixation and reproducing fixations of the Work, 
including storage of a protected performance or phonogram in digital form or other electronic 
medium.  
2. Fair Dealing Rights. Nothing in this License is intended to reduce, limit, or restrict any uses 
free from copyright or rights arising from limitations or exceptions that are provided for in connection 
with the copyright protection under copyright law or other applicable laws.  
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3. License Grant. Subject to the terms and conditions of this License, Licensor hereby grants 
You a worldwide, royalty-free, non-exclusive, perpetual (for the duration of the applicable copyright) 
license to exercise the rights in the Work as stated below:  
a. to Reproduce the Work, to incorporate the Work into one or more Collections, and to 
Reproduce the Work as incorporated in the Collections;  
b. to create and Reproduce Adaptations provided that any such Adaptation, including any 
translation in any medium, takes reasonable steps to clearly label, demarcate or otherwise identify 
that changes were made to the original Work. For example, a translation could be marked "The 
original work was translated from English to  
Spanish," or a modification could indicate "The original work has been modified.";  
c. to Distribute and Publicly Perform the Work including as incorporated in  
Collections; and,  
d. to Distribute and Publicly Perform Adaptations.  
e. For the avoidance of doubt:  
i. Non-waivable Compulsory License Schemes. In those jurisdictions in which the right to 
collect royalties through any statutory or compulsory licensing scheme cannot be waived, the 
Licensor reserves the exclusive right to collect such royalties for any exercise by You of the rights 
granted under this License;  
ii. Waivable Compulsory License Schemes. In those jurisdictions in which the right to collect  
royalties through any statutory or compulsory licensing scheme can be waived, the Licensor waives 
the exclusive right to collect such royalties for any exercise by You of the rights granted under this 
License; and,  
iii. Voluntary License Schemes. The Licensor waives the right to collect royalties, whether 
individually or, in the event that the Licensor is a member of a collecting society that administers 
voluntary licensing schemes, via that society, from any exercise by You of the rights granted under 
this License. The above rights may be exercised in all media and formats whether now known or 
hereafter devised. The above rights include the right to make such modifications as are technically 
necessary to exercise the rights in other media and formats. Subject to Section 8(f), all rights not 
expressly granted by Licensor are hereby reserved.  
4. Restrictions. The license granted in Section 3 above is expressly made subject to and limited 
by the following restrictions:  
a. You may Distribute or Publicly Perform the Work only under the terms of this License. You 
must include a copy of, or the Uniform Resource Identifier (URI) for, this License with every copy of 
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the Work You Distribute or Publicly Perform. You may not offer or impose any terms on the Work 
that restrict the terms of this License or the ability of the recipient of the Work to exercise the rights 
granted to that recipient under the terms of the License. You may not sublicense the Work.  
You must keep intact all notices that refer to this License and to the disclaimer of warranties with 
every copy of the Work You Distribute or Publicly Perform. When You Distribute or Publicly 
Perform the Work, You may not impose any effective technological measures on the Work that 
restrict the ability of a recipient of the Work from You to exercise the rights granted to that recipient 
under the terms of the License. This Section 4(a) applies to the Work as incorporated in a Collection, 
but this does not require the Collection apart from the Work itself to be made subject to the terms of 
this License. If You create a Collection, upon notice from any Licensor You must, to the extent 
practicable, remove from the Collection any credit as required by Section 4(b), as requested. If You 
create an Adaptation, upon notice from any Licensor You must, to the extent practicable, remove 
from the Adaptation any credit as required by Section 4(b), as requested.  
b. If You Distribute, or Publicly Perform the Work or any Adaptations or Collections, You 
must, unless a request has been made pursuant to Section 4(a), keep intact all copyright notices for the 
Work and provide, reasonable to the medium or means You are utilizing: (i) the name of the Original 
Author (or pseudonym, if applicable) if supplied, and/or if the Original Author and/or Licensor 
designate another party or parties (e.g., a sponsor institute, publishing entity, journal) for attribution 
("Attribution Parties") in Licensor's copyright notice, terms of service or by other reasonable means, 
the name of such party or parties; (ii) the title of the Work if supplied; (iii) to the extent reasonably 
practicable, the URI, if any, that Licensor specifies to be associated with the Work, unless such URI 
does not refer to the copyright notice or licensing information for the Work; and (iv) , consistent with 
Section 3(b), in the case of an Adaptation, a credit identifying the use of the Work in the Adaptation 
(e.g., "French translation of the Work by Original Author," or "Screenplay based on original Work by 
Original Author"). The credit required by this Section 4 (b) may be implemented in any reasonable 
manner; provided, however, that in the case of a Adaptation or Collection, at a minimum such credit 
will appear, if a credit for all contributing authors of the Adaptation or Collection appears, then as 
part of these credits and in a manner at least as prominent as the credits for the other contributing 
authors. For the avoidance of doubt, You may only use the credit required by this Section for the 
purpose of attribution in the manner set out above and, by exercising Your rights under this License, 
You may not implicitly or explicitly assert or imply any connection with, sponsorship or endorsement 
by the Original Author, Licensor and/or Attribution Parties, as appropriate, of You or Your use of the 
Work, without the separate, express prior written permission of the Original Author, Licensor and/or 
Attribution Parties.  
c. Except as otherwise agreed in writing by the Licensor or as may be otherwise permitted by 
applicable law, if You Reproduce, Distribute or Publicly Perform the Work either by itself or as part 
of any Adaptations or Collections, You must not distort, mutilate, modify or take other derogatory 
action in relation to the Work which would be prejudicial to the Original Author's honor or 
reputation. Licensor agrees that in those jurisdictions (e.g. Japan), in which any exercise of the right 
 
139  
    
granted in Section 3(b) of this License (the right to make Adaptations) would be deemed to be a 
distortion, mutilation, modification or other derogatory action prejudicial to the Original Author's 
honor and reputation, the Licensor will waive or not assert, as appropriate, this Section, to the fullest 
extent permitted by the applicable national law, to enable You to reasonably exercise Your right 
under Section 3(b) of this License (right to make Adaptations) but not otherwise.  
5. Representations, Warranties and Disclaimer  
UNLESS OTHERWISE MUTUALLY AGREED TO BY THE PARTIES IN WRITING,  
LICENSOR OFFERS  
THE WORK AS-IS AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY  
KIND  
CONCERNING THE WORK, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE,  
INCLUDING,  
WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTIBILITY, FITNESS FOR  
A PARTICULAR  
PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER  
DEFECTS,  
ACCURACY, OR THE PRESENCE OF ABSENCE OF ERRORS, WHETHER OR NOT  
DISCOVERABLE. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED 
WARRANTIES, SO SUCH EXCLUSION MAY NOT APPLY TO YOU.  
6. Limitation on Liability. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE  
LAW, IN NO  
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EVENT WILL LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY FOR ANY  
SPECIAL,  
INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES ARISING  
OUT OF THIS LICENSE OR THE USE OF THE WORK, EVEN IF LICENSOR HAS BEEN 
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.  
7. Termination  
a. This License and the rights granted hereunder will terminate automatically upon  
any breach by You of the terms of this License. Individuals or entities who have received Adaptations 
or Collections from You under this License, however, will not have their licenses terminated provided 
such individuals or entities remain in full compliance with those licenses. Sections 1, 2, 5, 6, 7, and 8 
will survive any termination of this License.  
b. Subject to the above terms and conditions, the license granted here is perpetual (for the 
duration of the applicable copyright in the Work). Notwithstanding the above, Licensor reserves the 
right to release the Work under different license terms or to stop distributing the Work at any time; 
provided, however that any such election will not serve to withdraw this License (or any other license 
that has been, or is required to be, granted under the terms of this License), and this License will 
continue in full force and effect unless terminated as stated above.  
8. Miscellaneous  
a. Each time You Distribute or Publicly Perform the Work or a Collection, the Licensor offers 
to the recipient a license to the Work on the same terms and conditions as the license granted to You 
under this License.  
b. Each time You Distribute or Publicly Perform an Adaptation, Licensor offers to the recipient 
a license to the original Work on the same terms and conditions as the license granted to You under 
this License.  
c. If any provision of this License is invalid or unenforceable under applicable law, it shall not 
affect the validity or enforceability of the remainder of the terms of this License, and without further 
action by the parties to this agreement, such provision shall be reformed to the minimum extent 
necessary to make such provision valid and enforceable.  
d. No term or provision of this License shall be deemed waived and no breach consented to 
unless such waiver or consent shall be in writing and signed by the party to be charged with such 
waiver or consent.  
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e. This License constitutes the entire agreement between the parties with respect to the Work 
licensed here. There are no understandings, agreements or representations with respect to the Work 
not specified here. Licensor shall not be bound by any additional provisions that may appear in any 
communication from You. This License may not be modified without the mutual written agreement 
of the Licensor and You.  
f. The rights granted under, and the subject matter referenced, in this License were  
drafted utilizing the terminology of the Berne Convention for the Protection of  
Literary and Artistic Works (as amended on September 28, 1979), the Rome  
Convention of 1961, the WIPO Copyright Treaty of  
1996, the WIPO Performances and Phonograms Treaty of 1996 and the Universal Copyright 
Convention (as revised on July 24, 1971). These rights and subject matter take effect in the relevant 
jurisdiction in which the License terms are sought to be enforced according to the corresponding 
provisions of the implementation of those treaty provisions in the applicable national law. If the 
standard suite of rights granted under applicable copyright law includes additional rights not granted 
under this License, such additional rights are deemed to be included in the License; this License is not 
intended to restrict the license of any rights under applicable law.  
Creative Commons Notice  
Creative Commons is not a party to this License, and makes no warranty whatsoever in connection 
with the Work. Creative Commons will not be liable to You or any party on any legal theory for any 
damages whatsoever, including without limitation any general, special, incidental or consequential 
damages arising in connection to this license. Notwithstanding the foregoing two (2) sentences, if 
Creative Commons has expressly identified itself as the Licensor hereunder, it shall have all rights 
and obligations of Licensor.  
Except for the limited purpose of indicating to the public that the Work is licensed under the CCPL, 
Creative Commons does not authorize the use by either party of the trademark "Creative Commons" 
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or any related trademark or logo of Creative Commons without the prior written consent of Creative 
Commons. Any permitted use will be in compliance with Creative Commons' then-current trademark 
usage guidelines, as may be published on its website or otherwise made available upon request from 
time to time. For the avoidance of doubt, this trademark restriction does not form part of this License. 
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Appendices 
Appendix A: Human ERG Studies 
Purpose: To record STR waveforms in a human participant using the protocols designed for chick 
ERG testing with similar levels of light control and dark adaptation  
Method: ERGs were recorded from one human subject (male black, 38yrs) after ethical approval 
(ORE 22678) for the study was obtained from Human Research Ethics Committee of University of 
Waterloo.  After informed consent, the visual acuity, intraocular pressure, and anterior chamber 
assessments were recorded, then eyes were dilated with 1% tropicamide (Alcon Inc., Mississauga, 
ON, Canada). After achieving pupil dilation of > 6 mm diameter, the ERGs were recorded bilaterally 
from the cornea using standard DTL® fiber electrodes (Diagnosys LCC, Lowell, MD, USA).  
References were standard EEG skin electrodes (Fenton Tech. Inc., Markham, ON, Canada) placed on 
the lateral canthus and a ground placed on the right wrist. Two micro-manipulators (one for each eye) 
were used to hold and position the ganzfeld such that each eye was were looking at center of its 
ganzfeld. Protocols completed included those used for the main studies of the chick. Specifically, the 
dark- and light-adapted protocols (section 3.8.1 and 3.8.2). For dark-adapted ERGs, eyes were dark 
adapted for 20 min, and for light adapted ERGs, eyes were light adapted to the background (see Table 
1 and Table 2) for 10 min.   
Results: This study revealed that given the same protocol/stimulus parameters, STRs with both a 
negative and positive waveform are recordable in humans. The human negative STR was apparent for 
stimuli between -5.25 and -4.25 log cd.s/m2. As the use of the same instruments, recording parameters 
and light stimulus levels elicited STRs in the human subject but not in the chicks (Figure 34), also 
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gives credence to the suggestion by this study that chicks might not have STRs.  The LA-ERG results 




    
Appendix B: Human Ethics 
Dear Researcher:  
  
A University of Waterloo Research Ethics Committee is pleased to inform you 
the study named below has been reviewed and given ethics clearance.    
  
  
Title: Electrophysiological Measure of Retinal Ganglion Cells Function in 
humans ORE #: 22678 Faculty Supervisor: Daphne McCulloch 
(daphne.mcculloch@uwaterloo.ca) Faculty Supervisor: Vivian Choh  
(vchoh@uwaterloo.ca) Student Investigator: Clement Afari  
(clement.afari@uwaterloo.ca)  
  
A signed copy of the notification of ethics clearance will be sent to the 
Principal Investigator (or Faculty Supervisor in the case of student 
research). Ethics approval to start this research is effective as of the date 
of this email. The above named study is to be conducted in accordance with 
the submitted application (Form 101/101A) and the most recent approved 
versions of all supporting materials.   
  
University of Waterloo Research Ethics Committees operate in compliance with 
the institution's guidelines for research with human participants, the Tri-
Council Policy Statement for the Ethical Conduct for Research  
Involving Humans (TCPS, 2nd edition), Internalization Conference on  
Harmonization: Good Clinical Practice (ICH-GCP), the Ontario Personal Health 
Information Protection Act (PHIPA), and the applicable laws and regulations 
of the province of Ontario. Both Committees are registered with the U.S. 
Department of Health and Human Services under the Federal Wide Assurance, 
FWA00021410, and IRB registration number IRB00002419  
(Human Research Ethics Committee) and IRB00007409 (Clinical Research Ethics 
Committee).   
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Appendix C: Animal Ethics 
UNIVERSITY OF WATERLOO 
OFFICE OF RESEARCH ETHICS 
ANIMAL CARE COMMITTEE 
CERTIFICATE OF FULL ETHICS APPROVAL: 
RENEWAL OF ANIMAL UTILIZATION PROJECT PROPOSAL (LAST RENEWAL) 
All research and teaching activities at the University of Waterloo which use live, non-human 
vertebrate animals must be conducted in compliance with the Animals for Research Act of Ontario 
(Revised Statutes of Ontario), the Guide to the Care and Use of Experimental Animals from the 
Canadian Council on Animal Care and the University of VVateloo's Guidelines for the Care and Use 
of Animals in Research and Teaching. 
Principal Investigator(s): 
Department or School: 
Co-Investigator(s): 
Student Investigator(s): 
Projoct Title • 
AUPP # : 
Number of Animals 
Approved: 
Vivian Choh;  
Optometry; 
Daphne McCulloch; 
Clement Afari; Ziqing Li; 
Comparison of three tests that measure retinal ganglion cell function in 
chickens 
15-11 Approval Date: May 29, 2018 
66 Chickens Invasiveness Category: c 
The above Animal Utilization Project Proposal (AUPP) Renewal Form has been reviewed by 
members of the Animal Care Committee at the University of Waterloo in compliance with the 
requirements of the Animals for Research Act, the Canadian Council on Animal Care's Guide to the 
Care and Use of Experimental Animals, and the University's Guidelines for the Care and Use of 
Animals in Research and Teaching. 
Approval of the original AUPP is extended for an additional twelve month period from the date 
shown. 
This year's renewal represents the last of the 4 year renewal cycle under Animal Care Committee 
guidelines since an AUPP representing continuing research may be renewed three times only after 
original ethics approval. In the event you wish to continue this project beyond May 2019, you will 
need to submit a full AUPP not later than the end of April 2019 in order to avoid any break in ethics 
approval status. 
Note: the project covered by this AUPP must be conducted according to the procedures described in 
the application. Requests for subsequent modifications to approved AUPPs must be communicated in 
writing to the Research Ethics Advisor, Office of Research Ethics, using the Modification Form. 
 
Research Ethics Advisor 
Office of Research Ethics 
https://oreprod.private.uwaterloo.ca/ethics/animals/aupp/ad/AUPPrenewal certificate.asp?i...  
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                                      Appendix D: DA Stimulus Response Curves 
Stimulus response curves form the DA chickens from the ONS group. The order of graph is day 0, 3, 
4,5,7 post-baseline.  
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Appendix E: Naka-Rushton Curve Fitting R Codes 
 
   
Naka-Rushton curve fitting  
Coded by Vivian Choh, vchoh@uwaterloo.ca  
Modified with permission by Clement Afari, a5clemen@uwaterloo.ca  
######  Set up function to fit  ##### 
library(tcltk) require(nlmrt) library(nls2) 
library(ggplot2)  
log.fit <- "y ~ sqrt(a^2)/(1+(x/sqrt(x0^2))^-1)"  
  
#####  Initialise files   ##### 
if(exists("NRdata.a")) {rm(NRdata.a)} 
if(exists("NRdata.b")) {rm(NRdata.b)}  
  
#####  Read in data and set out.path  ##### df <- df[, 
colSums(is.na(df)) != nrow(df)] my.out.path <- 
tclvalue(tkchooseDirectory()  
  
#####  Find expected variables in data file  ##### 
birdName <- unique(df$Bird) whichWeek <- 
unique(df$week) fit.a <- unique(df$a.amp) fit.b <- 
unique(df$b.amp)  
  
#####  Assuming multiple weeks and multiple birds  #####  weekNum = 
whichWeek[weekLoop]  
  
  124  
#####  Assuming multiple weeks and multiple birds  #####  
weekNum = whichWeek[weekLoop]              
     
#####  Assuming multiple number of birds   #####  
whichBird = birdName[birdLoop]                
       
 #####  For the individual bird at a certain time point   #####    
  
